The Longevity Digest 06/09 - 06/15

I'm cutting through the noise in longevity and anti-aging podcasts so you don't have to.

Welcome to The Longevity Digest.

I’ve curated specific shows that consistently deliver evidence-based insights you can actually use. Think less fluff, more substance. The kind of information that changes how you practice or how you live.

Got a podcast that’s been delivering gold? Send it my way. I’m always hunting for voices that push the field forward.

This Newsletter Is Sponsored By Casa de Sante.

---

Dr Onyx MD PhD’s Insights on this week’s episodes

1. Longevity Is Moving From “One-Size-Fits-All” To N‑of‑1 Systems Biology

The center of gravity in longevity is shifting from guideline-based risk reduction to precision control of an individual’s inflammatory, vascular, and mitochondrial “operating system.” On The Human Upgrade episode “Why Are Hackers Microdosing ‘Sex Drugs’ Now?” clinicians framed longevity care as N‑of‑1 systems biology: multi‑omics, autonomic tone, and vascular/mitochondrial status are treated as the primary levers, with drugs and devices sequenced around those readouts rather than age or population averages.

This shows up in three converging moves. First, precision biomarker panels are getting teeth. Several Human Upgrade episodes push beyond standard lipids to homocysteine, ApoB, Lp(a), TGF‑β1, MMP‑9, C4a, nitric oxide biology, and even membrane lipidomics as “control dials” for microvascular inflammation and perfusion. Second, autonomic and vascular tools are no longer fringe. Vagal nerve stimulation to suppress NLRP3, HRV‑tracked breathwork, intermittent hypoxic–hyperoxic training, red/near‑IR photobiomodulation, PEMF, HBOT, and stacked EWOT+PBM protocols are being deployed to fix “pseudo‑hypoxia” at the tissue level even when pulse oximetry looks normal. Third, mitochondrial-directed therapeutics are leaving theory and entering practice: urolithin A as a mitophagy activator with human data on mitochondrial gene expression and immune remodeling, and high‑polyphenol, methylation‑supportive diets that can measurably lower epigenetic age in eight weeks.

Strategically, this reframes the clinic from “risk factor suppression” to “infrastructure engineering.” As Dr. Kara Fitzgerald’s appearance on The Human Upgrade and the urolithin A episode both underline, nutrition and postbiotics can push epigenetic and mitochondrial programs toward a younger state in weeks, not decades, if dosed and tracked correctly. The implication for executives and clinicians is operational: build care pathways that start with multi‑omic and vascular/autonomic mapping, then layer targeted pharmacology (metformin, rapamycin, GLP‑1s, PDE5 inhibitors, peptides) only after the core system variables are understood and monitored. That also means investing in longitudinal metrics—PWV, HRV, VO2 proxies, epigenetic clocks—rather than one‑off labs, because the goal is trend control, not single numbers.

---

This Newsletter Is Sponsored By Casa de Sante.

For anyone on GLP-1 medications like Ozempic or Wegovy, Low FODMAP nutrition is non-negotiable. These medications can slow digestion and trigger bloating or nausea, so choosing gut-friendly products helps you stay comfortable while protecting muscle and metabolism. Physician-formulated by Dr Onyx MD PhD Certified in Obesity Management, this Low FODMAP lineup supports nutrient absorption, muscle defense, and overall digestive balance:

• Premium Protein Powder (Vegan Vanilla, Whey Vanilla, or Whey Chocolate) – helps preserve lean muscle during weight loss

• FODMAP Digestive Enzymes – improves absorption and reduces GI side effects

• Advanced Probiotic + Prebiotic Synbiotic Formula – supports a balanced gut microbiome

• Essential Vitamin & Mineral Complex – replenishes nutrients often depleted during rapid weight loss

• Gentle Colon Cleanse + Probiotic Support – aids regular elimination without irritation

All formulas are low FODMAP, non-GMO, and third-party tested—the ideal foundation for GLP-1 users focused on digestive comfort, metabolic health, and muscle preservation.

Because hormones and skin health are deeply connected, Dr Onyx MD PhD science-backed skincare supports barrier repair, hydration, and inflammation balance for healthy, resilient skin—especially during menopause or while using GLP-1 medications, when collagen loss and dryness can accelerate:

• HydraLift Collagen Complex – firms and smooths for youthful elasticity

• Antioxidant C+E Ferulic Radiance Serum – brightens and defends against oxidative stress

• Needle-Free Wrinkle Smoother – softens fine lines without irritation

• Ultra Retinol 10x + Bakuchiol Serum – boosts cell turnover with gentle plant retinol

• Advanced Retinol Eye Repair – targets puffiness and under-eye wrinkles

• Cellular Repair Growth Factor Peptides Serum – rejuvenates and supports skin repair

• Advanced Neck Lift Firming Complex – improves tone and texture along the jawline and neck

• Even Tone Brightening Cream – evens discoloration for radiant, balanced skin

Dr Onyx Adegbola MD PhD
Track Smarter. Eat Better. Thrive. Download the GLP1 Support App at https://casadesante.com/pages/app-glp-1-support-by-dr-onyx-md-phd

---

2. Behavior And Environment Are Being Treated As High‑Yield “Hidden Drugs”

Across multiple episodes, the most potent levers for brain, metabolic, and cardiovascular longevity are not new molecules but re‑engineered daily inputs—light, sleep timing, environment, food processing, and social contact—treated with the same seriousness as pharmacotherapy. On Huberman Lab’s “Essentials: Sleep Toolkit,” light becomes a prescribed drug: morning outdoor light to set cortisol and circadian phase, late‑day light to buffer against nighttime exposure, and aggressive reduction of overhead light between 10 p.m. and 4 a.m. as a first‑line therapy for nearly all sleep complaints. Couple that with evidence that irregular bedtimes double major cardiovascular events and you get a crisp, clinically relevant message: circadian regularity is now a cardiology target, not just a wellness suggestion, as highlighted on The Human Upgrade “Semen Switch, Chewing Gum, Creatine Cheat, Cancer Plants, and Bedtime Risk.”

Diet is undergoing a similar reframing. Jim O’Neill’s episode on The Human Upgrade makes explicit that U.S. federal guidance is pivoting toward whole‑food, higher‑protein patterns with less fear of saturated fat, while Dr. Jason Fung’s repeated appearances argue that obesity is fundamentally a hunger and conditioned‑cue problem driven by ultra‑processed foods—not a willpower or calorie‑math deficit. Taken together, these conversations suggest that clinicians who focus on food quality, meal timing, and environment (removing ultra‑processed foods, instituting fasting windows, redesigning cues) will outperform traditional calorie‑restriction paradigms, and that GLP‑1s should be viewed as appetite‑modulating adjuncts rather than primary solutions.

The same “behavior as drug” logic extends to social and environmental exposures. Huberman Lab episodes with Dr. Dacher Keltner and Dr. Nick Epley recast awe practices and graded social exposure as low‑cost interventions that shift vagal tone, inflammation, pain, and social anxiety risk, while The Human Upgrade episodes on indoor mold and microplastics elevate air, building, and product choices to core cardiovascular and cognitive risk factors. Clinically, that means adding targeted environmental history (water damage, dust, vehicle exposures, chewing gum use, microplastic sources) and social exposure prescriptions to routine visits, because these “silent” variables are now directly tied to mitochondrial function, endothelial health, and long‑term mortality.

3. Longevity Is Colliding With Frontier Tech, Policy, And Ethics

Finally, the frontier is no longer just mechanistic science; it is a live negotiation between radical new tools, regulatory shifts, and societal behavior. On Health Longevity Secrets’ explainer about epigenetic reprogramming, partial OSK‑based gene therapies (e.g., Life Biosciences’ ER100 for glaucoma/NAION) illustrate how the Information Theory of Aging is moving from mouse to human trials, effectively treating epigenetic information loss as a druggable root cause of aging. Meanwhile, The Human Upgrade’s “Pandemic Fever Is BACK, Testosterone and Brain Tumors, Rabies, and Dog Flu” and “Putin Longevity, Pancreatic Cancer Cure, AI Therapy, GLP‑1 Breast Cancer…” episodes underscore how infectious threats, hormone–cancer interactions, GLP‑1–linked reductions in breast cancer risk, and even oncolytic virotherapy in pancreatic cancer are coming online in a regulatory climate where court decisions and national megaprojects (e.g., Russia’s state‑scale anti‑aging initiative) can rapidly reshape access and data transparency.

Neuromodulation and AI sit at the other edge of this collision. On Huberman Lab’s “Essentials: Compulsive Behaviors & Deep Brain Stimulation,” Dr. Casey Halpern describes a future in which DBS, MRgFUS, TMS, and closed‑loop systems targeted to ventral striatal “craving” signals become mainstream tools for severe OCD, addiction, and binge eating, while The Human Upgrade episodes on AI chatbots warn that nearly one in five young people are already using AI for emotional support. Add to that the emergence of AI‑enabled smart toilets for passive cancer and gut‑health surveillance, and you get a clear through‑line: continuous, AI‑mediated monitoring and brain/body modulation are moving from lab to living room.

For strategists, the implication is twofold. First, governance, consent, and data provenance must be designed into longevity offerings from day one—whether you are deploying multi‑omic platforms, autonomous toilets, or neuromodulation trials—because the line between clinical care, consumer tech, and surveillance is blurring fast. Second, leaders should expect regulatory whiplash: shifts in FDA authority, rapid GLP‑1 expansion, forthcoming aging biomarker validation via ARPA‑H, and nation‑state longevity programs will change what “standard of care” looks like on a 3–5 year horizon. The durable edge will belong to organizations that can integrate hard science (epigenetic and mitochondrial interventions, vascular metrics), behavioral architecture (light, sleep, food environment, social exposure), and responsible tech (AI, wearables, neuromodulation) into coherent, ethically grounded longevity operating systems.

One question that will shape how you act on this: in your current or planned practice/organization, is the main bottleneck scientific validation, regulatory risk, or patient/consumer adoption?

This weeks episodes:

1. The Human Upgrade: Biohacking for Longevity & Performance

Why Are Hackers Microdosing “Sex Drugs” Now? : 1425

Published: 2026-03-03

URL: Listen Here

Summary

This episode advocates for precision medicine that integrates multi-omic data, autonomic modulation, and targeted therapeutics to optimize longevity. It highlights vagal nerve stimulation’s ability to downregulate the NLRP3 inflammasome, the need to individualize drugs and peptides, and the centrality of vascular tone/perfusion and mitochondrial function to healthy aging. Some claims are anecdotal and product-related; specific study details were not always provided in the discussion.

Key Takeaways

• Precision medicine should move beyond one-size-fits-all epidemiology to N-of-1 care using multi-omics (genomics → transcriptomics → proteomics → metabolomics/exposome) to match the right intervention to the right person at the right time.

• Vagal nerve stimulation engages the cholinergic anti-inflammatory pathway (α7nAChR/JAK–STAT/NF-κB) and can downregulate the NLRP3 inflammasome, a central driver of systemic inflammation and fibrosis; simple adjuncts like EGCG may also modulate NLRP3 activity.

• Longevity pharmacology must be individualized: metformin is not universally beneficial (mitochondrial blunting/VO2 max concerns), rapamycin safety data are emerging (PEARL trial) but endpoints matter, and low-dose, pathway-targeted use of drugs and peptides (e.g., BPC-157, KPV, CJC-1295 with ipamorelin, PT-141) can have bioregulatory effects when used judiciously.

• Vascular tone and perfusion are foundational to brain and sexual health; strategies include nitric oxide support, selective PDE5 inhibitor use (e.g., low-dose tadalafil in appropriate patients), and device-based approaches like acoustic shockwave therapy, which may promote neovascularization and lower MMP-9.

• Actionable biomarkers beyond routine labs that inform aging biology include homocysteine, ApoB, Lp(a), TGF-β1, MMP-9, and C4a; pairing these with mitochondrial/energy-oriented interventions (IHHT, photobiomodulation, PEMF, HBOT) and exposome assessment can improve outcomes while AI can help sequence interventions efficiently.

Clinical Insight

Targeting autonomic balance and inflammatory set-points—specifically via vagal nerve stimulation to suppress NLRP3—combined with multi-omic profiling provides a practical, high-leverage way to personalize longevity care beyond traditional risk-factor management.

Actionable Takeaway

In patients with chronic inflammation or dysautonomia, add MMP-9 and homocysteine (along with ApoB, Lp(a), TGF-β1, and C4a when feasible) to baseline labs; if elevated, trial a noninvasive vagal nerve stimulation protocol to engage the cholinergic anti-inflammatory pathway and reassess biomarkers after 6–8 weeks.

2. The Human Upgrade: Biohacking for Longevity & Performance

Why Are Hackers Microdosing “Sex Drugs” Now? : 1425

Published: 2026-03-03

URL: Listen Here

Summary

This episode explores how precision medicine leverages multi-omics, exposome assessment, and autonomic modulation to individualize care, with practical discussion of peptides, low-dose pharmaceuticals (e.g., tadalafil), and advanced biomarkers beyond standard panels. The conversation emphasizes sequencing interventions for mitochondrial and vascular health, measuring transcriptomic responses to confirm epigenetic effects, and safeguarding data as personalized platforms mature.

Key Takeaways

• Precision medicine requires an N-of-1, multi-omic approach (genomics, transcriptomics, proteomics, epigenetics, metabolomics, exposomics) to match the right intervention to the right person at the right time.

• Autonomic modulation, particularly vagal nerve stimulation, can downregulate inflammatory pathways (e.g., NLRP3 inflammasome via the cholinergic anti-inflammatory pathway) and may improve longevity-relevant markers; EGCG was cited as a practical adjunct.

• Microdosing or low-dose use of select pharmaceuticals (e.g., tadalafil for vascular tone) and emerging peptide therapeutics (e.g., BPC-157, KPV, CJC-1295 with ipamorelin/semorelin, PT-141) can be useful for targeted outcomes but should be sequenced thoughtfully; metformin and rapamycin are not universal longevity solutions.

• Beyond routine labs, clinicians should consider biomarkers that reflect inflammation and vascular health such as homocysteine, MMP-9, TGF-β1, C4a, nitric oxide-related function, and even cell membrane lipidomics; low cerebral perfusion is common and clinically meaningful.

• Biohacking technologies (e.g., intermittent hypoxic–hyperoxic training, photobiomodulation, PEMF, HBOT, acoustic shockwave) can be potent when applied in the right order and tracked with objective data; data privacy and ownership matter as multi-omic and exposome assessments scale.

Clinical Insight

Shifting from population averages to multi-omic, N-of-1 care—while actively modulating the autonomic nervous system—allows physicians to directly influence and verify changes in key inflammatory and vascular pathways (e.g., NLRP3, nitric oxide biology), improving precision and efficiency of interventions.

Actionable Takeaway

For patients with chronic inflammation, dysautonomia, or low perfusion, implement daily noninvasive vagal nerve stimulation (or paced-breathing/HRV training) for 10–20 minutes and track CRP/IL-6 and symptom changes; consider adding a well-tolerated green tea extract providing 200–400 mg EGCG/day as an NLRP3-modulating adjunct, checking for drug–supplement interactions.

3. The Human Upgrade: Biohacking for Longevity & Performance

Your AC Is Making You Dumber : 1444

Published: 2026-04-03

URL: Listen Here

Summary

This episode argues that air-conditioning and water‑damaged indoor environments expose occupants to mycotoxins that impair mitochondrial function, cognition, hormones, metabolism, and sleep, with variable susceptibility driven partly by HLA‑DR genetics. The hosts outline a cost‑conscious, stepwise approach to ‘detoxing’ homes and vehicles—fix moisture/HVAC, oxidize/degrade mycotoxins and VOCs, reseed with environmental probiotics, and protect high‑risk surfaces—alongside humidity and dust control. Limitations: many claims are experiential or product‑specific and not independently detailed in the episode; clinicians should interpret promotional elements cautiously and corroborate with evidence-based resources.

Key Takeaways

• Toxic mold and their mycotoxins (e.g., ochratoxin A, zearalenone) are fat‑soluble mitochondrial poisons that can drive multisystem illness—neurocognitive deficits, sleep disturbance with vivid nightmares, mood/behavior changes, endocrine disruption (thyroid, estrogen dominance), weight gain, easy bruising, recurrent infections, and chemical sensitivity.

• Susceptibility varies widely; genetics (e.g., HLA‑DR4 variants) and exposure history modulate risk, so one family member may be severely affected while others appear well. Brain SPECT data (Amen Clinics) suggest mold exposure can reduce prefrontal activity and cognition but may be reversible after remediation.

• Built environments—especially HVAC systems, ductwork, dust, moisture-prone areas, and vehicles—are common and underrecognized exposure sources; ingestion via mold‑prone foods (coffee, grains, peanuts) also contributes.

• Effective management pairs medical care with environmental strategies: identify and fix moisture sources, control indoor humidity (~40–50%), address HVAC and duct contamination, reduce dust, and consider staged decontamination (oxidizing fog/gas to degrade mycotoxins and VOCs, reseeding with environmental probiotics, and protective coatings on high‑risk surfaces).

• Porous belongings can carry residual mycotoxins between homes; moving without decontaminating contents often perpetuates illness. Vehicles (cars/RVs) can be significant sources due to mold and VOCs; targeted ‘detox’ is different from standard detailing.

Clinical Insight

In patients with persistent, unexplained multisystem symptoms (fatigue/brain fog, sleep disruption, mood/behavior changes, weight dysregulation, chemical sensitivity), assessing and treating the home/vehicle environment—especially moisture control and HVAC/dust contamination—can be decisive for recovery from mycotoxin-related illness.

Actionable Takeaway

Screen for water‑damaged building exposure in symptomatic patients and recommend a basic home assessment: measure/maintain indoor humidity at 40–50%, use HEPA air filtration and HEPA vacuuming to reduce dust, inspect/clean HVAC and ducts, and initiate validated environmental testing (e.g., dust-based mycotoxin or ERMI/HERTSMI‑2) before escalating medications.

4. The Human Upgrade: Biohacking for Longevity & Performance

Your AC Is Making You Dumber : 1444

Published: 2026-04-03

URL: Listen Here

Summary

Dave Asprey and the SuperStratum team discuss how indoor mold and residual mycotoxins can impair mitochondrial function and contribute to wide-ranging symptoms, with variable patient susceptibility. They outline practical, staged approaches for homes and vehicles—addressing moisture control, HVAC/duct hygiene, dust removal, and targeted decontamination of mycotoxins/VOCs—to complement or follow traditional remediation.

Key Takeaways

• The episode centers on indoor mold and mycotoxins as underrecognized drivers of diverse symptoms (fatigue, brain fog, sleep disturbance, mood changes, endocrine disruption, weight gain) via mitochondrial dysfunction and immune dysregulation.

• Susceptibility varies widely; about 28% of people may carry HLA-DR4 variants associated with heightened inflammatory responses and reduced ability to clear fat-soluble mycotoxins, which helps explain why household members can be affected differently.

• Common exposure sources include water-damaged buildings, high indoor humidity, HVAC/ductwork, dust accumulation, and vehicles; ochratoxin A (OTA) and zearalenone are highlighted as clinically relevant mycotoxins with thyroid and estrogenic effects, respectively.

• Post-remediation illness can persist due to residual mycotoxins and VOCs on surfaces and in contents; the discussion emphasizes whole-home strategies: fix moisture sources, maintain 40–50% indoor RH, clean/coat HVAC and ducts, HEPA vacuum dust, and consider targeted decontamination approaches.

• The guests discuss a staged approach they use (fogging/‘bombing’ to oxidize mycotoxins/VOCs, followed by environmental probiotics and durable anti-microbial coatings) as a lower-cost adjunct to traditional remediation, and note cars can require similar detox protocols.

Clinical Insight

In patients with otherwise unexplained neurocognitive, endocrine, sleep, or cardiometabolic complaints—especially with a history of dampness or water damage—environmental mycotoxin exposure is a plausible, often overlooked contributor; assessing susceptibility, the built environment (not just visible mold), and residual mycotoxins after remediation can materially influence outcomes.

Actionable Takeaway

Incorporate a brief environmental history and screening into visits for chronic, multisystem complaints: ask about water damage/musty odors, humidity levels, HVAC maintenance, visible condensation, dust burden, and car exposures; advise maintaining indoor RH ~40–50%, fixing moisture intrusions, HEPA vacuuming dust, servicing/cleaning HVAC and ducts, and consider referral to qualified mold assessment/remediation when indicated.

5. Huberman Lab

Cultivating Awe & Emotional Connection in Daily Life | Dr. Dacher Keltner

Published: 2026-04-06

URL: Listen Here

Summary

This episode details the science of awe—how shifting from narrow to vast perception, engaging with nature and music, and synchronizing in groups reliably evokes awe with tangible benefits across inflammation, vagal tone, pain, and well-being. Practical protocols (e.g., awe walks) offer clinicians scalable tools to augment care, while insights on social bonding (embarrassment/teasing) and carefully supervised psychedelic-assisted therapy highlight additional pathways to strengthen connection and resilience. Note: Some findings (e.g., long COVID improvements from brief daily awe) are preliminary and require further peer-reviewed validation.

Key Takeaways

• Awe is a measurable, health-relevant state linked to increased vagal tone (HRV), reduced inflammation, lower physical pain, and reported improvement in long COVID symptoms from brief daily awe practices.

• Shifting perceptual “aperture” from small to vast (for example, moving from focusing on a leaf to the canopy to the sky/horizon) reliably evokes awe and can recalibrate arousal, time perception, and self-focus toward equanimity.

• An 8-week, once-weekly 20–30 minute “awe walk” intervention in older adults increased awe, kindness, and vast attention in daily life and reduced bodily pain, with longer-term follow-up suggesting brain health benefits.

• Group synchrony (music, sport, dance, chanting, shared rituals) rapidly fosters bonding and collective identity, consistent with the concept of collective effervescence; embarrassment and prosocial teasing within groups signal commitment to norms and strengthen cohesion.

• Psychedelics (classic serotonergic agents) can induce profound awe and may aid treatment-resistant conditions (e.g., end-of-life anxiety, depression, PTSD) when used in structured, safe, culturally respectful settings; microdosing lacks strong clinical evidence.

Clinical Insight

Awe can be deliberately elicited (nature, music, horizons, group synchrony) and functions as a low-cost, low-risk adjunct that measurably improves autonomic balance (vagal tone), reduces inflammatory load and pain, and supports mental health—making it a viable element to integrate into preventive care and rehabilitation plans.

Actionable Takeaway

Prescribe a weekly 20–30 minute awe walk for 8 weeks: ask patients to slow their pace and breath (prolonged exhalations), and to move attention from small to vast (e.g., a leaf → tree → treeline → clouds/horizon). Encourage one brief daily “micro-awe” (≈60 seconds via nature, music, or vistas). Track simple outcomes (pain ratings, mood/sleep, HRV if available) and consider adding music- or nature-based sessions for reinforcement.

6. Huberman Lab

Essentials: The Biology of Aggression, Mating & Arousal | Dr. David Anderson

Published: 2026-04-09

URL: Listen Here

Summary

This episode reviews the neurobiology of internal states governing aggression, mating, and arousal, emphasizing hypothalamic circuit logic, hormone signaling (notably estrogen pathways), and brain–body interactions. It highlights how social isolation engages conserved tachykinin mechanisms that amplify aggression and anxiety, suggesting concrete translational avenues (e.g., NK3 antagonists) while underscoring the clinical need to assess and address isolation.

Key Takeaways

• Emotions are best understood as internal brain states (like arousal or motivation) that reshape input–output transformations of neural circuits; unlike reflexes, they often persist beyond the trigger and generalize across contexts.

• Aggression is a heterogeneous set of behaviors supported by distinct but adjacent hypothalamic circuits (VMHvl): fear-related neurons can hierarchically suppress offensive aggression, and VMH integrates multisensory inputs while broadcasting low-dimensional ‘attack pressure’ signals widely.

• Sex hormones do not map simply onto behavior: estrogen receptor–expressing neurons in male VMH are necessary for aggression, many testosterone effects are mediated via aromatization to estrogen, and in females, discrete VMH ER+ neuron subsets differentially control mating versus fighting.

• Mating and aggression circuits exhibit reciprocal control: activating medial preoptic area (MPOA) ‘mating’ neurons can abruptly switch a male from fighting to courtship, whereas VMHvl ‘aggression’ neurons bias toward attack; PAG acts as a downstream ‘switchboard’ coordinating pain modulation and innate action patterns.

• Social isolation robustly upregulates tachykinin signaling (e.g., tachykinin 2) across species, increasing aggression, fear, and anxiety; in mice, an NK3 receptor antagonist (osanotont) reverses isolation-induced phenotypes without sedation, highlighting a translational target for isolation-related psychopathology.

Clinical Insight

Social isolation is a potent, biologically mediated driver of negative affect and aggression—partly via tachykinin 2 signaling—with preclinical evidence that NK3 receptor antagonism can normalize isolation-induced aggression, fear, and anxiety without sedation; clinicians should treat isolation as a modifiable risk factor rather than a benign social state.

Actionable Takeaway

Routinely screen patients for social isolation (e.g., recent bereavement, living alone, limited social contact) and implement mitigation strategies—structured social engagement, therapy referrals, family/caregiver involvement, and follow-up touchpoints—especially in individuals showing increased irritability, anxiety, or aggression.

7. Huberman Lab

Essentials: The Biology of Aggression, Mating & Arousal | Dr. David Anderson

Published: 2026-04-09

URL: Listen Here

Summary

This episode synthesizes neural circuit, hormonal, and neuropeptide mechanisms underlying aggression, mating, arousal, and pain modulation. Key themes include hypothalamic control of offensive aggression and its suppression by fear, estrogenic regulation of male aggression, sex-specific VMH circuits for mating vs fighting, and tachykinin-driven effects of social isolation that are reversible with NK3R antagonism—findings with clear translational relevance for stress-related behavioral health.

Key Takeaways

• Emotions are best understood as internal brain states (like arousal, motivation, sleep) that transform how inputs map to outputs; compared to reflexes, emotion states show persistence and generalization beyond the initial trigger.

• Aggression is a behavior that can arise from different internal states (e.g., anger, fear, hunger); in mice, ventromedial hypothalamus (VMHvl) circuits drive offensive, positively valenced aggression, while adjacent hypothalamic fear circuits can hierarchically suppress fighting.

• Hormonal control of aggression in males depends critically on estrogen receptor–expressing VMH neurons and aromatization of testosterone to estrogen; estrogen implants can restore aggression in castrated male mice.

• Sex-specific neural architecture shapes behavior: in females, distinct estrogen receptor–positive VMH subsets separately control mating and fighting, and medial preoptic area (MPOA) ‘mating’ neurons can acutely suppress ongoing aggression (antagonistic VMH–MPOA interactions).

• Social isolation upregulates tachykinin signaling (Tac2/neurokinin B) across the brain to increase aggression, fear, and anxiety; an NK3 receptor antagonist (osanetant) reverses these effects in mice. The periaqueductal gray (PAG) acts as a hub for innate behaviors and supports endogenous, state-dependent analgesia (e.g., during fear/defense).

Clinical Insight

Chronic social isolation induces a Tac2/NK3R-mediated, druggable brain state that heightens aggression, fear, and anxiety—highlighting both the clinical importance of assessing isolation/bereavement and the translational potential of NK3 receptor antagonism for stress-related behavioral dysregulation.

Actionable Takeaway

Routinely screen patients experiencing prolonged social isolation or bereavement for irritability, aggression, and anxiety, and implement structured social reconnection strategies (e.g., group therapy, regular follow-ups, community engagement) to mitigate these biologically primed risk states.

8. The Human Upgrade: Biohacking for Longevity & Performance

Why Doctors Can’t Fix Women in 2026 : 1446

Published: 2026-04-09

URL: Listen Here

Summary

This episode argues that modern care under-treats women’s hormones and that personalized, bioidentical HRT—especially estradiol and progesterone delivered vaginally at systemic doses—can be a cornerstone for restoring libido, cognition, mood, sleep, gut/gallbladder function, and overall vitality. The guests emphasize treating to clinical response (not just numbers), considering genetics and neurotransmitters, and leveraging nutrition (adequate protein, cautious fiber, iodine) while using testosterone judiciously. Note: Many claims were experiential and not directly cited; sponsor content and controversial viewpoints are included.

Key Takeaways

• Personalized, bioidentical hormone replacement (estradiol, progesterone, ± testosterone) is presented as foundational for many symptomatic women—even premenopausally—with dosing guided by symptoms and function rather than fixed lab ‘norms’ or low-dose patches/pills.

• Systemic vaginal delivery of estradiol and progesterone is advocated as higher bioavailability than oral/topical/patch routes, aiming to suppress elevated FSH and improve cognition, sleep, mood, gut/gallbladder function, and sexual function; oral progesterone’s sedating effects may arise from liver-derived metabolites.

• Testosterone can benefit women’s libido and cognition but excess transdermal/injected T may increase DHT/aromatization or disrupt the vaginal microbiome; many women may normalize T by optimizing progesterone, with optional low-dose topical T for event-based arousal.

• Diet and environment meaningfully influence hormones and neurotransmitters: prioritize adequate protein (supporting dopamine/COMT), avoid excessive insoluble fiber and certain phytoestrogens, consider iodine repletion for breast/uterine health, and be mindful of high-oxalate foods (e.g., matcha/spinach) implicated in kidney stones and tissue symptoms.

• Evaluate and treat holistically: use FSH and symptom clusters to detect early dysfunction, recognize genetic/epigenetic differences (e.g., COMT) in hormone clearance, consider neurotransmitter support (dopamine/norepinephrine/serotonin), and avoid focusing on thyroid alone when sex-hormone deficits drive multi-system complaints.

Clinical Insight

For women with multi-system symptoms (mood, sleep, gut, libido, cognitive), adequately dosed, bioidentical estradiol plus progesterone—preferably via systemic vaginal delivery—and personalized titration to clinical response can restore function across brain, immune, gut, and sexual domains; labs (including FSH) inform but should not replace symptom-guided care.

Actionable Takeaway

In an appropriate symptomatic woman (even <45), obtain FSH, estradiol, progesterone, total/free testosterone, SHBG, DHEA-S, and thyroid panel; if findings and history suggest ovarian under-function, initiate a trial of bioidentical estradiol + progesterone via systemic vaginal delivery and titrate every 6–8 weeks to symptom relief while reinforcing adequate protein intake and avoiding excessive insoluble fiber.

9. The Human Upgrade: Biohacking for Longevity & Performance

Superhuman Contact Lenses, Motivation Supplement Stack, Cat Scratches Cause Brain Fog, Amino Acid Shortening Lifespan, and more... : 1448

Published: 2026-04-10

URL: Listen Here

Summary

This episode highlights overlooked inputs—stealth infections, amino acid balance, sensory light processing, micronutrient status, and olfactory cues—that materially affect cognition, motivation, and autonomic tone. It offers practical steps clinicians can use now: targeted PCR testing for Bartonella, judicious lab monitoring around tyrosine, nutrient stacking to bolster motivation, and low-cost sensory strategies to reduce cognitive and stress load.

Key Takeaways

• Cat scratches/bites can transmit Bartonella, a stealth infection linked to chronic brain fog, mood instability, and fatigue; standard serology often misses it—PCR testing is preferred and may require referral to a Lyme-literate clinician.

• A Mendelian randomization analysis (~270,000 participants) associates higher circulating tyrosine with nearly one year shorter lifespan in men (not women), potentially via myeloperoxidase-driven formation of inflammatory meta-tyrosine; consider measuring plasma tyrosine and phenylalanine and avoiding unnecessary tyrosine supplementation, especially in men.

• Tinted contact lenses (Altius) reportedly reduce chromatic aberration by 53% and improve contrast by 20–30%, potentially lowering visual processing load and enhancing performance; spectrum-filtering eyewear (e.g., TrueDark) and screen apps (Flux/Iris) are adjuncts.

• A randomized, placebo-controlled crossover trial from the University of the Philippines found a 4-week stack (taurine 2 g, methylfolate 800 mcg, P5P 50 mg, methylcobalamin 1 mg) increased effort-based motivation and reduced attention lapses, plausibly via astrocytic glutathione support of prefrontal function.

• A Monell Chemical Senses Center analysis indicates a 30-second deep nasal inhalation of floral scents can lower heart rate by 5–10 bpm and shift autonomic tone toward parasympathetic; lavender has the strongest RCT support, but pleasant florals broadly appear effective.

Clinical Insight

In patients with persistent neurocognitive or mood symptoms and a history of cat scratches/bites, Bartonella infection is likely underrecognized; order a Bartonella PCR (not just serology) and consider referral to a tick-borne disease–literate clinician, as antibody tests can miss intracellular, tissue-resident infections.

Actionable Takeaway

For patients (especially men) using tyrosine-containing supplements or very high-protein diets, obtain a fasting plasma tyrosine and phenylalanine panel (Quest/LabCorp) and review inflammatory markers; avoid or reduce tyrosine supplementation if levels are high or the tyrosine:phenylalanine ratio approaches/exceeds 10:1.

10. The Human Upgrade: Biohacking for Longevity & Performance

CDC Director Jim O’Neill on Fixing America’s Broken Food Policy : 1449

Published: 2026-04-14

URL: Listen Here

Summary

This episode features Jim O’Neill outlining an HHS/CDC push to overhaul U.S. food guidance and aging research while refocusing CDC on infectious diseases. Highlights include whole‑food, higher‑protein dietary guidance with forthcoming RCTs on saturated fat, large ARPA‑H investments in causal aging biomarkers and organ bioprinting, and greater openness to AI, wearables, non‑pharma therapies, and GLP‑1s. Several claims are policy announcements or opinions presented without primary citations.

Key Takeaways

• The guest describes newly released federal dietary guidelines that emphasize whole and minimally processed foods, higher protein intake (1.2–1.6 g/kg/day), and allow meat and full‑fat dairy, while de-emphasizing refined grains and ultra‑processed foods; randomized controlled trials on saturated fats are being initiated.

• HHS is prioritizing rigorous replication and aging science, including a reported $144M ARPA‑H initiative to identify causal biomarkers of aging and an organ bioprinting program that has printed a pediatric heart/vasculature (not yet implanted).

• CDC is being refocused on infectious diseases, with examples cited of assisting to contain Ebola (DRC) and Marburg (Ethiopia), alongside a stated goal of rebuilding public trust through transparency.

• There is openness to evaluating non‑pharmaceutical interventions (e.g., ozone therapy) with the same standards as drugs, and to integrating AI and wearables into care and surveillance—paired with strong patient consent and privacy protections.

• Clinical and policy notes include support for GLP‑1s in obesity treatment, an ongoing review of upper vitamin D limits, and improvements to school meals aligned with the updated guidelines.

Clinical Insight

A shift toward whole‑food, higher‑protein nutrition with a more individualized view of dietary fats suggests clinicians should reassess grain‑centric, low‑fat counseling and focus on reducing ultra‑processed carbohydrates while tailoring fat and protein recommendations to each patient’s metabolic risk and goals.

Actionable Takeaway

For adult patients—especially those with metabolic syndrome risk or sarcopenia—calculate and document an individualized daily protein target of 1.2–1.6 g/kg from whole‑food sources, pair this with counseling to minimize ultra‑processed/refined carbohydrates, and reassess lipid/metabolic labs to tailor fat recommendations.

11. Huberman Lab

How Women Can Improve Their Fertility & Hormone Health | Dr. Natalie Crawford

Published: 2026-04-13

URL: Listen Here

Summary

Dr. Crawford details a proactive, science‑based roadmap for improving female fertility and hormone health: use AMH and ovulation tracking to detect issues early, leverage high‑impact lifestyle changes and targeted supplements during the “trimester zero,” and apply appropriate medical tools without waiting for failure. She emphasizes avoiding cannabis and nicotine, practical contraception off‑ramp timing, and clarifies that egg freezing/IVF do not reduce ovarian reserve, while highlighting select promising but still investigational therapies. Note: Summary reflects the provided transcript and may omit topics discussed outside these excerpts.

Key Takeaways

• Proactive fertility assessment matters: Anti-Müllerian Hormone (AMH) testing estimates ovarian reserve (not egg quality) and can guide life and treatment planning; it’s inexpensive (~$79) and useful even before trying to conceive.

• Track ovulation, not just periods: A luteal phase <11 days is an early red flag for ovulatory dysfunction; avoid NSAIDs except during menses because they can block follicle rupture and ovulation.

• Lifestyle and exposures strongly influence fertility and hormone health: Prioritize sleep (7–9 h), stress control, muscle building, anti-inflammatory nutrition, and toxin minimization; avoid cannabis and nicotine (both sexes), which impair gametes and increase miscarriage risk.

• Evidence-supported preconception supplements: Begin a prenatal (with folate), CoQ10, omega-3 fatty acids, and vitamin D; for male partners, add L‑carnitine (± zinc/selenium). Consider low-dose melatonin (1–3 mg) for sleep/inflammation preconception, then stop in pregnancy.

• Clinical nuances: Egg freezing/IVF do not deplete ovarian reserve; stop combined OCPs 3–6 months before trying to learn ovulation, remove levonorgestrel IUD ~6 months before attempting conception, and avoid Depo‑Provera if planning pregnancy within 1–2 years. Selective, emerging tools (e.g., GLP‑1s in insulin resistance/inflammation, intrauterine PRP for implantation failure) show promise; ovarian PRP and red light remain investigational.

Clinical Insight

Replace the “fail‑first” model with an early, data‑driven approach: normalize AMH screening and ovulation/luteal‑phase tracking for reproductive‑age women to surface problems sooner and tailor timely lifestyle, medical, or procedural interventions that can materially improve outcomes.

Actionable Takeaway

At routine visits for women who might want children, offer AMH testing and brief ovulation‑tracking education, and initiate a 60–90‑day preconception plan: sleep 7–9 h; avoid cannabis/nicotine and NSAIDs outside menses; start prenatal (folate), CoQ10 (200–400 mg/day), omega‑3 (1–2 g/day EPA+DHA), vitamin D per level; counsel partners to add L‑carnitine (≈2 g/day); reassess promptly if luteal phase <11 days, cycles irregular, age ≥35, or ≥2 pregnancy losses.

12. The Human Upgrade: Biohacking for Longevity & Performance

CDC Director Jim O’Neill on Fixing America’s Broken Food Policy : 1449

Published: 2026-04-14

URL: Listen Here

Summary

Acting CDC Director Jim O’Neill outlines a pivot in U.S. food policy toward whole foods and away from ultra‑processed, grain‑heavy patterns, alongside active trials reassessing saturated fats. He details federal investments in causal aging biomarkers via ARPA‑H, broader acceptance of AI and wearables (with consent) in care, a renewed CDC focus on infectious diseases, support for GLP‑1s in obesity management, and a review of vitamin D limits. Several points reflect evolving policy announcements described in the interview.

Key Takeaways

• HHS/CDC leadership reports newly announced U.S. dietary guidelines that emphasize whole, minimally processed foods, reduce reliance on grains and ultra-processed foods, and affirm that meat and full‑fat dairy can fit into a healthy diet; randomized controlled trials on saturated fats are underway.

• The government is prioritizing replication and rigor, including a $144M ARPA-H initiative to develop and FDA‑validate causal biomarkers of aging to enable surrogate endpoints for prevention and longevity therapies.

• CDC is refocusing on infectious disease and highlights recent collaborations that contained Ebola (DRC) and Marburg (Ethiopia), while rebuilding public trust via transparency and focus.

• There is openness to testing non‑pharmaceutical and biohacking innovations (e.g., ozone therapy) with the same scientific standards, and expanded use of wearables and AI for early detection and clinical decision support, with strong emphasis on privacy and informed consent.

• GLP‑1 receptor agonists are supported as effective tools for obesity when paired with nutrition and fitness, vitamin D upper‑limit recommendations are under review, and school meals are viewed as a high‑leverage point for improving national nutrition.

Clinical Insight

Expect a policy shift in federal nutrition guidance—toward whole, minimally processed foods with adequate protein and without blanket avoidance of saturated fat/full‑fat dairy—which, combined with GLP‑1 use where appropriate, can reshape counseling and management of obesity and cardiometabolic disease.

Actionable Takeaway

Update nutrition counseling now: guide patients to prioritize whole foods and minimize ultra‑processed/refined grains, target 1.2–1.6 g/kg/day protein, individualize recommendations on saturated fat based on cardiometabolic risk, and routinely measure 25‑OH vitamin D with supplementation as needed under monitoring.

13. The Human Upgrade: Biohacking for Longevity & Performance

1 Cup Every Morning Helped Me Lose 100 Pounds (Drink THIS) : 1452

Published: 2026-04-19

URL: Listen Here

Summary

This episode is a first‑person narrative promoting butter/MCT coffee, intermittent fasting, and a high‑fat, low‑grain approach while labeling common nutrition beliefs as myths and de‑emphasizing exercise for fat loss. It reflects popular biohacking perspectives but provides limited primary evidence; clinicians may encounter patients adopting these strategies and should contextualize them within current guidelines and individualized risk assessment.

Key Takeaways

• Host Dave Asprey attributes losing over 100 pounds to starting mornings with “butter coffee” (grass‑fed butter + MCT oil) and practicing intermittent fasting, emphasizing satiety, steady energy, and reduced cravings.

• He presents nine “myths” he believes hinder weight loss: saturated fat is harmful; low‑fat diets are healthy; calories‑in/calories‑out drives weight change; frequent small meals boost metabolism; all vegetables are beneficial (citing anti‑nutrients in some); whole grains are healthy; fruit is universally healthy (warns about fructose); breakfast is essential; and exercise is the primary tool for fat loss.

• Asprey advocates prioritizing saturated fats from grass‑fed animal sources and coconut oil, avoiding trans fats and processed seed/vegetable oils, minimizing grains and high‑fructose fruits, and selecting lower anti‑nutrient vegetables.

• He claims mold/mycotoxins in some coffees drive jitters and poorer tolerance, recommending “clean” coffee; he also argues diet quality and fasting outweigh exercise for fat loss and warns that overtraining may elevate cortisol.

• The episode is largely anecdotal and promotional, referencing his books and commercial products; specific primary research citations supporting many claims are not provided.

Clinical Insight

Patients may inquire about high‑fat morning beverages and time‑restricted eating to curb hunger and aid weight management; clinicians should individualize guidance and, if trialed, monitor cardiometabolic risk (e.g., LDL‑C/apoB, glycemia, liver enzymes) given that several assertions—especially high saturated fat intake and broad avoidance of plant foods/grains—diverge from prevailing evidence‑based guidelines.

Actionable Takeaway

When patients ask about “butter coffee” or intermittent fasting, offer a short, supervised 2–4 week trial of time‑restricted eating (e.g., 14–16 hour daily fast) focused on minimally processed foods; advise non‑caloric morning beverages in higher‑risk patients, track hunger/weight/glucose, and recheck lipids as indicated before making longer‑term changes.

14. The Human Upgrade: Biohacking for Longevity & Performance

Jason Fung: 3 Rules to Lose 50 Pounds Without Ever Counting a Calorie : 1453

Published: 2026-04-21

URL: Listen Here

Summary

Jason Fung contends that contemporary obesity is driven primarily by hedonic and conditioned hunger magnified by ultra-processed foods and pervasive eating cues, not by a simple excess of calories. He outlines three rules—ditch ultra-processed foods, reintroduce fasting windows, and engineer environments—to lower hunger and make weight loss sustainable, positioning GLP‑1 medications as appetite-lowering tools to use alongside real‑food and behavior change.

Key Takeaways

• Hunger has three distinct drivers—homeostatic (physical), hedonic (pleasure), and conditioned (cue-driven/social)—and the latter two dominate modern overeating.

• Ultra-processed foods are engineered to maximize reward and minimize satiety (rapid absorption, texture modifiers, emulsifiers, flavor enhancers), amplifying hedonic and conditioned hunger independent of calories.

• Sustained weight loss rarely results from calorie restriction alone; approaches that reduce hunger (diet quality, meal timing/fasting, environmental redesign) work better. GLP-1 receptor agonists help mainly by suppressing appetite but require concurrent habit change for durability.

• Fung’s three golden rules: eliminate ultra-processed foods; include consistent fasting periods (reduce meal frequency/snacking); and redesign schedules/environments to remove eating cues and food noise.

• Behavioral and mindset tools—such as extinction and counter-conditioning, eating only at a table, and reframing ultra-processed items as “not food”—can deprogram conditioned hunger and reduce cravings.

Clinical Insight

For patients with obesity, target hunger biology and conditioned cues rather than caloric math: assess and modify diet quality (real food over ultra-processed), structure meal timing (fasting windows), and reshape social/environmental triggers; consider GLP-1 agents to reduce appetite while concurrently coaching durable nutrition and behavioral skills.

Actionable Takeaway

At the next visit, screen for the three hunger types and initiate a 4‑week protocol: eliminate ultra-processed foods; eat 2–3 real‑food meals within an 8–10‑hour window with no calories between; and remove eating cues (no eating in the car/TV, keep snacks out of sight). If on a GLP‑1, pair with nutrition/behavioral coaching to build lasting habits.

15. The Human Upgrade: Biohacking for Longevity & Performance

Jason Fung: 3 Rules to Lose 50 Pounds Without Ever Counting a Calorie : 1453

Published: 2026-04-21

URL: Listen Here

Summary

This episode reframes obesity care around managing hunger biology and learned cues rather than prescribing calorie restriction. Fung explains how ultra-processed foods and ubiquitous food cues amplify hedonic and conditioned hunger, and outlines three practical rules—cut UPFs, add fasting windows, and redesign environments—to align physiology and behavior. GLP-1 medications can help by suppressing hunger, but sustained success depends on concurrent nutrition and behavioral retraining.

Key Takeaways

• Overeating is primarily a hunger problem—not a calorie problem—with three contributors: homeostatic (physical), hedonic (pleasure-driven), and conditioned (cue-driven) hunger; in modern environments, conditioned and hedonic hunger dominate.

• Ultra-processed foods are engineered to maximize reward (rapid absorption, intense flavors, optimized texture) while minimizing satiety, reinforcing both hedonic and conditioned hunger and driving habitual overconsumption.

• Calorie restriction alone fails long term because physiology adapts and hunger intensifies; focusing on reducing hunger signals via food quality, structured fasting, and behavioral strategies is more sustainable.

• GLP-1 receptor agonists reduce hunger and can enable weight loss, but durable results require concurrent learning of real-food eating patterns and environment/cue redesign to prevent relapse when medications stop.

• Dr. Fung’s three golden rules: (1) eliminate ultra-processed foods; (2) establish consistent fasting windows and stop constant snacking; (3) redesign schedules and environments to reduce food cues, using counterconditioning and extinction to retrain conditioned hunger.

Clinical Insight

For sustained weight loss, clinicians should target the biology and behavior of hunger—especially conditioned and hedonic drivers—by replacing ultra-processed foods with real foods, implementing time-based fasting windows, and modifying environments/cues; pharmacologic appetite suppression (e.g., GLP-1 RAs) can be an adjunct but must be paired with nutrition and behavior change to maintain results.

Actionable Takeaway

Start a two-week intervention: advise patients to remove ultra-processed foods from home/work, eat 2–3 whole-food meals daily with adequate protein and natural fats, avoid between-meal snacks, and keep a 12–14-hour overnight fast; restrict eating to a table (not cars/TV) and replace evening snacking with unsweetened tea to extinguish conditioned cues, then reassess hunger/craving patterns at follow-up.

16. The Human Upgrade: Biohacking for Longevity & Performance

Jason Fung: 3 Rules to Lose 50 Pounds Without Ever Counting a Calorie : 1453

Published: 2026-04-21

URL: Listen Here

Summary

Dr. Jason Fung reframes weight loss around hunger biology and environment, arguing that hedonic and conditioned hunger—amplified by ultra-processed foods and pervasive cues—drive overeating more than true physical hunger. Sustainable management targets appetite regulation (real food, fasting windows, environment design, behavioral techniques) and may incorporate GLP-1 therapy as a tool while patients build lasting dietary and behavioral skills.

Key Takeaways

• Obesity is driven by three types of hunger—homeostatic (physical), hedonic (pleasure-driven), and conditioned (social/cue-driven)—with conditioned and hedonic hunger now dominating due to environment, marketing, and constant food cues.

• Chronic calorie restriction fails long-term because appetite and hormones (e.g., insulin, GLP-1 pathways) govern intake and expenditure; GLP-1 receptor agonists work by lowering hunger but require concurrent nutrition and behavior change for durable results.

• Ultra-processed foods (UPFs) are engineered to maximize reward (rapid absorption, flavor enhancers, emulsifiers/texturizers) and minimize satiety, amplifying ‘food noise,’ cravings, and overeating; additives like carrageenan/xanthan gum can worsen mouthfeel-driven intake and may irritate the gut.

• Fung’s three golden rules: (1) eliminate UPFs in favor of real, nutrient-dense foods; (2) ensure an adequate fasting window and stop constant snacking; (3) redesign schedule and environment (eat at a table, avoid eating while driving/TV, manage cues) to reduce conditioned hunger.

• Behavioral strategies such as counterconditioning (pairing cravings with aversive imagery) and extinction/substitution (e.g., tea instead of snacks while watching TV), plus a mindset shift to view UPFs as “not food,” help deprogram conditioned eating.

Clinical Insight

Effective obesity care centers on diagnosing and treating hunger dysregulation (hedonic and conditioned drivers) and hormonal responses to food, not prescribing simple calorie restriction; prioritize removal of ultra-processed foods, structured fasting/eating windows, and environmental cue control, using GLP-1s as adjuncts to reduce hunger while patients learn durable eating behaviors.

Actionable Takeaway

Start a 2–4 week ‘real food + fasting’ trial: remove all ultra-processed items and sweetened/‘diet’ beverages; eat 2–3 real-food meals daily emphasizing protein and natural fats; maintain a 12–16 hour overnight fast with no snacking; and restrict eating to a table—then reassess hunger, satiety, and weight at follow-up.

17. The Human Upgrade: Biohacking for Longevity & Performance

Inside Kambo: Poison, Purging, and The People Who Swear By It : 1455

Published: 2026-04-24

URL: Listen Here

Summary

This episode examines Kambo’s traditional origins, modern ceremonial use, administration, peptide-based mechanisms, safety profile, and preliminary human outcomes. It highlights practical risk-reduction (especially electrolyte management), underscores the paucity of rigorous clinical data, and discusses sustainability and training standards relevant to clinicians advising patients exploring Kambo.

Key Takeaways

• Kambo (frog skin secretion from Phyllomedusa bicolor) is applied via superficial skin burns and is not a classical psychedelic; it induces a rapid, intense 20–30 minute experience marked by flushing, tachycardia, nausea/vomiting, sweating, shaking, transient facial swelling (“frog face”), and possible bowel movements or syncope.

• Traditional Amazonian use centered on ‘hunting magic’ (adaptogenic effects like heightened perception and stamina); modern practice emphasizes ritual, trauma work, and broad wellness aims, with anecdotal utility reported for pain, autoimmune issues, infections, metabolic disease, and addiction.

• Pharmacology involves at least 27 peptide analogs across eight families (e.g., opioid-receptor–active and vagal-acting peptides, antimicrobial peptides) producing vascular, GI, autonomic, and possible antipsychotic effects; however, rigorous human research on the full Kambo cocktail is sparse.

• Safety hinges on preventing hyponatremia from overhydration (especially when stacked with low-salt ayahuasca dieta/fasting) and supervising to mitigate aspiration and falls; with careful screening, electrolyte management, and close monitoring, serious adverse events appear uncommon.

• Emerging data (practice datasets, a post-session survey, and a prospective human study pending publication) suggest improvements in mood, mindfulness, happiness, pain, and fatigue after Kambo; sustainability and standardization remain challenges, spurring conservation work and attempts to characterize/synthesize peptide mixtures.

Clinical Insight

Kambo is a peptide-rich, non-psychedelic intervention with meaningful autonomic, GI, antimicrobial, and opioid-receptor effects that may yield short-term improvements in mood, mindfulness, and pain—yet its safe application in practice depends primarily on rigorous screening and proactive electrolyte management to prevent hyponatremia.

Actionable Takeaway

If a patient plans to undergo Kambo, counsel them to avoid overhydration: use salted fluids or oral electrolyte solution (e.g., add 1/4–1/2 tsp sea salt per liter of water), avoid low-salt/fasting protocols and stacking with ayahuasca within 24–48 hours, and ensure the session is supervised by a trained practitioner who monitors for syncope/aspiration.

18. Huberman Lab

Male Roles, Obligations and Options for Building a Fulfilling Life | Scott Galloway

Published: 2026-04-27

URL: Listen Here

Summary

This episode examines modern male roles and well-being, advancing a positive masculinity framework (provider–protector–procreator plus service) and concrete habits that build purpose, skills, and relationships. It highlights Big Tech’s role in compulsive use and isolation, advocates for mentorship and national service, and outlines policy levers (antitrust, algorithmic liability, age-gating) and personal behaviors clinicians can reinforce to improve mental health and social outcomes.

Key Takeaways

• Galloway proposes a constructive masculinity code—provider, protector, procreator—augmented by service and the goal of creating “surplus value” (giving more than one takes).

• Practical plan for struggling young men: reclaim screen time; train hard (≥3x/week); work outside the home (~30 hrs/week when feasible); engage weekly in team/service groups; and practice graded social “approaches,” embracing rejection as a skill-builder.

• Big Tech and algorithmic feeds foster compulsive phone use, isolation, and polarization; policy remedies discussed include antitrust actions, algorithmic liability (Section 230 reform), and age-gating social media for minors.

• Male mentorship and (ideally) national service are framed as high-yield solutions to purpose, skill development, and social cohesion—especially critical for boys lacking an involved male role model.

• Societal/economic context matters: wealth transfer from young to old, higher-ed gatekeeping, and limited vocational on-ramps are linked to male underachievement and relationship/fertility headwinds; clinicians should recognize porn overuse as an under-researched, potentially demotivating behavior, while alcohol/THC can be net harmful or helpful depending on context and use patterns.

Clinical Insight

For young and midlife men, social isolation coupled with compulsive digital use (better conceptualized as an OCD-like compulsion loop than simple ‘dopamine hits’) is a potent driver of anxiety, depression, and suicidality; brief clinical screening and counseling that redirect time toward structured exercise, out-of-home work/school, service/mentorship, and graded real-world social engagement can meaningfully improve mental health and functioning.

Actionable Takeaway

In visits with adolescent and young adult males, add a 4-point screen—1) daily screen time and app limits, 2) exercise ≥3 days/week (resistance and/or endurance), 3) hours spent working or studying outside the home, 4) weekly group/service participation—then prescribe a 2–4 week trial to reallocate at least 8 hours/week from phone use to those activities and provide a mentorship or Big Brothers Big Sisters referral if a stable male role model is lacking.

19. The Human Upgrade: Biohacking for Longevity & Performance

The Strangest Thing I Do Every Morning for 15 Minutes | Brad Pitzele : 1458

Published: 2026-04-30

URL: Listen Here

Summary

This episode outlines how EWOT and red/near-infrared light therapy can be mechanistically complementary: exercise-driven hyperoxia improves oxygen delivery while PBM increases mitochondrial oxygen demand and nitric oxide–mediated microvascular perfusion. The approach targets endothelial and mitochondrial dysfunction implicated in fatigue, chronic inflammation, and recovery limitations, with a practical protocol of 15 minutes of EWOT followed by immediate PBM. Few specific clinical trials were cited during the conversation; recommendations were largely mechanistic and experiential.

Key Takeaways

• Exercise with Oxygen Therapy (EWOT) delivers ~93% oxygen during 10–15 minutes of light-to-moderate exercise using a concentrator and large reservoir bag, leveraging exercise-induced increases in ventilation, heart rate, vasodilation, and pressure gradients to drive oxygen deeper into tissues than resting oxygen supplementation.

• Chronic inflammation and endothelial dysfunction impair microcirculation (pseudo-hypoxia) even when pulse oximetry is normal; swollen endothelial cells and less-flexible RBCs limit capillary oxygen delivery, pushing cells toward anaerobic metabolism, ROS production, and a self-reinforcing inflammatory loop.

• Red/near-infrared photobiomodulation (PBM) enhances mitochondrial function by increasing oxygen demand and releasing nitric oxide for vasodilation; stacking PBM immediately after EWOT (when circulation and tissue oxygen levels are elevated) amplifies outcomes (energy, sleep, pain, recovery).

• A practical stack advocated: ~15 minutes of EWOT followed immediately by 10–20 minutes of red/NIR light (multiple red and NIR wavelengths) targeted to symptomatic areas or whole body to pair oxygen supply with mitochondrial uptake.

• Potential use cases discussed include fatigue, long-COVID/lung injury, endothelial and microvascular dysfunction, ‘anaerobic’ infections (e.g., Lyme), and detox support; the episode’s claims were primarily mechanistic and experiential, with few specific trials cited.

Clinical Insight

Tissue-level hypoxia from microvascular/endothelial dysfunction can persist despite normal SpO2; combining EWOT to enhance oxygen delivery with photobiomodulation to increase mitochondrial oxygen utilization and nitric oxide–mediated perfusion may help break cycles of low energy, inflammation, and impaired recovery.

Actionable Takeaway

For appropriate patients, trial a stacked protocol: 10–15 minutes of moderate EWOT (reservoir-fed ~93% FiO2) followed immediately by 10–15 minutes of red/NIR photobiomodulation (e.g., 620–660 nm and 800–1050 nm) targeted to key regions (e.g., lungs, neck/shoulders, lower limbs), while monitoring HR/BP/SpO2 and tracking functional markers (symptoms, 6MWT/VO2 proxy, and if available pulse wave velocity). Screen for contraindications to high FiO2 and follow oxygen safety protocols.

20. The Human Upgrade: Biohacking for Longevity & Performance

The Strangest Thing I Do Every Morning for 15 Minutes | Brad Pitzele : 1458

Published: 2026-04-30

URL: Listen Here

Summary

This episode explores how EWOT and red/near-infrared light target complementary sides of cellular energetics: EWOT boosts oxygen delivery during exercise, while photobiomodulation increases mitochondrial oxygen use and nitric oxide signaling. By addressing endothelial/microcirculatory dysfunction and mitochondrial inefficiency—common in aging and chronic disease—the combined approach may enhance energy, recovery, and vascular health, with practical protocols feasible at home.

Key Takeaways

• Exercise with Oxygen Therapy (EWOT) uses a concentrator and large reservoir to deliver ~93% oxygen during 15 minutes of moderate exercise, leveraging exercise-induced vasodilation and pressure gradients to drive oxygen deeper into hypoxic tissues.

• Aging and chronic illness often feature microcirculatory dysfunction and endothelial swelling that block red blood cells from reaching capillaries, creating tissue-level “pseudo-hypoxia” despite normal pulse oximetry; mitochondria then shift to low-yield anaerobic metabolism with more inflammatory byproducts.

• Red/near-infrared light (photobiomodulation) complements EWOT by increasing mitochondrial oxygen demand and efficiency (e.g., cytochrome c oxidase effects) and by promoting nitric oxide–mediated vasodilation, improving energy production and microvascular function.

• Stacking protocol: complete a 15-minute EWOT session, then immediately apply red/near-IR light (10–15 minutes) to capitalize on elevated circulation and oxygen availability; simultaneous use is possible but less practical.

• Discussed benefits include improved energy, sleep, pain, skin quality, recovery, and potential support in conditions with microvascular/mitochondrial dysfunction (e.g., Lyme, post-viral/long-COVID lungs), along with practical access to home EWOT systems and broad-spectrum red/IR devices.

Clinical Insight

Tissue hypoxia from microvascular and endothelial dysfunction can persist with normal SpO2 and underlies many chronic symptoms; combining strategies that enhance oxygen delivery (EWOT) with those that increase mitochondrial oxygen utilization and nitric oxide–driven vasodilation (red/near-IR light) may restore cellular energy and improve function in select patients.

Actionable Takeaway

For appropriately screened patients, implement a stack 3–5 times weekly: 15 minutes of EWOT at moderate exertion using a reservoir-fed concentrator (~93% O2), followed immediately by 10–15 minutes of red/near-IR photobiomodulation directed to priority regions (e.g., thorax for lung issues or large muscle groups); track response via symptoms (energy, sleep, pain) and, when available, vascular metrics (e.g., pulse wave velocity).

21. The Human Upgrade: Biohacking for Longevity & Performance

The Strangest Thing I Do Every Morning for 15 Minutes | Brad Pitzele : 1458

Published: 2026-04-30

URL: Listen Here

Summary

This episode explains how EWOT and red/near‑infrared light therapy can be combined to address mitochondrial dysfunction and microcirculatory ‘pseudo-hypoxia’ that underlie many chronic symptoms. The discussion emphasizes endothelial health, nitric oxide–mediated vasodilation, arterial stiffness (pulse wave velocity), and the lung’s role in detoxification, offering a practical sequencing strategy (EWOT, then PBM) to enhance energy, recovery, and tissue oxygenation. Limitations: the conversation is expert opinion–heavy and promotional in parts, and does not cite specific peer‑reviewed studies.

Key Takeaways

• Exercise with oxygen therapy (EWOT) uses a concentrator and large reservoir (~93% O2) to deliver high oxygen flow during 10–15 minutes of moderate exercise, leveraging exercise-induced vasodilation and pressure gradients to drive oxygen deeper into tissues.

• Stacking red/near-infrared photobiomodulation (PBM) immediately after EWOT exploits elevated circulation and oxygen availability to increase mitochondrial oxygen demand and efficiency, enhancing energy production, recovery, pain relief, and potentially sleep, skin, and sexual function via nitric oxide signaling.

• Endothelial health and microcirculation are central: inflammation causes endothelial swelling and reduced RBC deformability, creating ‘pseudo-hypoxia’ (normal SpO2 but poor tissue oxygenation) that shifts mitochondria to inefficient anaerobic metabolism and a pro-inflammatory ‘doom loop.’

• Arterial stiffness is an aging biomarker (e.g., pulse wave velocity); exercise and PBM can increase nitric oxide, improve vasodilation, and may support arterial flexibility and downstream tissue oxygenation.

• Lungs are major detox organs (~70% of toxin elimination); adequate oxygen is required for biotransformation and repair. EWOT may support recovery in post-viral/lung injury states by improving cellular oxygenation and mitochondrial energy needed for healing.

Clinical Insight

Sequenced therapy—EWOT to rapidly elevate tissue oxygen supply followed immediately by PBM to raise mitochondrial oxygen demand—can help overcome tissue-level ‘pseudo-hypoxia,’ restore aerobic metabolism, and improve microcirculatory function in patients with chronic inflammation, endothelial dysfunction, or post-illness fatigue.

Actionable Takeaway

Implement a clinic protocol: 10–15 minutes of EWOT (reservoir-fed ~93% O2) at moderate intensity (elevated HR/respiratory rate) followed within 5 minutes by 10–20 minutes of PBM (combined red ~630–680 nm and near-infrared ~800–1050 nm) targeted to symptomatic regions (e.g., thorax for lung, large muscle groups, or generalized exposure). Monitor SpO2/HR/BP, start with conservative dosing, and track outcomes (e.g., 6MWT, symptom scores, VO2 max trend, pulse wave velocity/microvascular assessments). Screen for photosensitizing meds and cardio-pulmonary contraindications.

22. The Human Upgrade: Biohacking for Longevity & Performance

Eat These Foods + Spices for 8 Weeks To Get 3 Years Younger | Kara Fitzgerald : 1461

Published: 2026-05-05

URL: Listen Here

Summary

This episode highlights clinical and mechanistic evidence that diet rich in methyl donors and polyphenols—supported by foundational lifestyle practices—can reverse epigenetic age within weeks, with nutrients doing the ‘heavy lifting.’ It also explores the frontier of Yamanaka factor biology and PRC2-linked ‘programmatic’ aging, proposing that select polyphenols may partially mimic reprogramming effects. Limitations include multimodal design (potential confounding), reliance on specific clocks, and that ‘Yamanaka mimetic’ strategies are largely preclinical.

Key Takeaways

• An 8-week randomized controlled dietary and lifestyle program emphasizing methyl-donor foods and polyphenol-rich ‘methylation adaptogens’ reduced biological age by over three years on the Horvath epigenetic clock in healthy middle-aged men; subsequent analysis suggested nutrients—especially dense polyphenols—were the primary drivers.

• The protocol featured 7–11 cups/day of fruits, vegetables, herbs, and spices; methylation-supportive foods (e.g., leafy greens, eggs, beets, liver); and included meditation, sleep hygiene, and exercise, with the control group’s exercise likely making exercise effects a wash.

• Polyphenols (e.g., EGCG from green tea; culinary herbs like rosemary, oregano, marjoram, thyme; and targeted options like urolithin A) may modulate gene expression and epigenetic marks; supplements can layer on top of diet for therapeutic dosing, though diet provides synergistic ‘information’ not captured by single compounds.

• Emerging work on Yamanaka factors and polycomb repressive complex 2 (PRC2) suggests a ‘programmatic’ component of aging; early evidence indicates caloric restriction and potentially select polyphenols could act as ‘Yamanaka mimetics’ to nudge youthful epigenetic programs (largely preclinical at present).

• First-generation clocks (e.g., Horvath) may capture aspects of programmatic aging; newer measures (e.g., DunedinPACE) are useful for tracking pace of aging. Case reports indicate women can also achieve meaningful bioage improvements with similar nutrition-forward protocols.

Clinical Insight

A targeted, food-first intervention emphasizing methyl-donor nutrients and high–polyphenol intake—augmented by basic lifestyle practices—can measurably and rapidly lower epigenetic age; in this cohort, the nutritional components appeared to account for most of the effect.

Actionable Takeaway

Implement an 8-week methylation-supportive nutrition plan (7–11 cups/day of diverse plants and polyphenol-rich herbs/spices; plus methyl donors like leafy greens, eggs, beets, and liver), alongside meditation and sleep hygiene; consider layering targeted polyphenol and metabolic supplements (e.g., EGCG, urolithin A, alpha‑ketoglutarate, sodium butyrate) as appropriate, and measure epigenetic age (e.g., Horvath/DunedinPACE) pre- and post-intervention to assess impact.

23. Huberman Lab

Essentials: Compulsive Behaviors & Deep Brain Stimulation | Dr. Casey Halpern

Published: 2026-05-07

URL: Listen Here

Summary

Dr. Casey Halpern outlines how compulsive behaviors arise from dysregulated cortico-striatal reward circuits and how neuromodulation—DBS, TMS, and MRgFUS—can be leveraged to treat refractory cases, with immediate efficacy in movement disorders and growing promise in psychiatry. The episode emphasizes personalized, symptom-evoked targeting and the integration of invasive recordings, noninvasive tools, and machine learning to advance precision therapies for OCD, addiction, and eating disorders.

Key Takeaways

• Deep brain stimulation (DBS) and MR-guided focused ultrasound (MRgFUS) can precisely modulate small brain regions; DBS provides adjustable electrical therapy via implanted electrodes, while MRgFUS enables incisionless ablation—both are highly effective for tremor and are being explored for psychiatric indications.

• Obsessive-compulsive disorder (OCD) involves dysregulation of cortico-striatal circuits, especially the ventral striatum/nucleus accumbens, which gate reward-seeking versus compulsive behaviors; similar circuitry underlies addiction and binge-eating.

• First-line OCD treatments include SSRIs/tricyclics and exposure and response prevention (ERP) therapy; about 30% remain symptomatic, and in severe refractory cases, DBS or capsulotomy yields roughly 50% response rates but often with residual symptoms—highlighting the need for more precise, symptom-specific targeting.

• Noninvasive neuromodulation is advancing: TMS is FDA-approved for depression, OCD, and nicotine addiction; MRgFUS is FDA-approved for essential tremor and tremor-dominant Parkinson’s disease, with research into modulatory ultrasound and blood–brain barrier opening; stereo-EEG (sEEG) is being leveraged to define better targets for psychiatric diseases.

• Emerging approaches seek to detect and interrupt pathologic urges (e.g., craving/obsession cells) using intraoperative recordings, lab-based mood/craving provocation paradigms, and machine learning—aiming for closed-loop, personalized interventions; awareness helps less severe cases but is often insufficient for the most refractory patients.

Clinical Insight

Compulsive behaviors across OCD, addiction, and binge-eating share a core dysfunction in ventral striatal reward/limbic circuits (notably the nucleus accumbens); targeted and personalized circuit modulation—guided by symptom-evoked neural signatures—offers a path to improve outcomes beyond current ~50% response rates from conventional DBS/lesional approaches.

Actionable Takeaway

For patients with OCD who remain symptomatic after adequate SSRI/tricyclic trials and ERP, refer to a specialized neuromodulation center to evaluate FDA-cleared transcranial magnetic stimulation (TMS) for OCD and to discuss candidacy and expectations for investigational DBS/capsulotomy in severe, treatment-refractory cases.

24. Huberman Lab

Essentials: Compulsive Behaviors & Deep Brain Stimulation | Dr. Casey Halpern

Published: 2026-05-07

URL: Listen Here

Summary

This episode outlines how compulsive behaviors and OCD arise from dysregulated cortico–striatal–limbic circuits and how neuromodulation—from TMS to DBS and MRI-guided focused ultrasound—is being applied and refined to treat severe, refractory cases. It emphasizes circuit-specific targeting (e.g., ventral striatum/nucleus accumbens), closed-loop detection of craving/obsession signals, and the roles of ERP and pharmacotherapy as first-line treatments. Note: As an Essentials excerpt, procedural details and specific trial outcomes are summarized at a high level.

Key Takeaways

• Deep brain stimulation (DBS) delivers targeted electrical stimulation via implanted leads; transient effects (e.g., brief laughter or panic) reveal proximity to limbic circuits and have informed psychiatric applications beyond movement disorders.

• Obsessive-compulsive disorder (OCD) and related compulsive/impulsive syndromes involve hyperactive prefrontal/orbitofrontal regions and ventral striatal circuits (notably the nucleus accumbens) that gate reward and compulsion; circuit-informed targeting is central to therapy development.

• First-line OCD care includes SSRIs or clomipramine (tricyclics) and exposure and response prevention (ERP); ~30% remain refractory, and current surgical options (DBS or capsulotomy) achieve about a 50% responder rate, with residual symptoms common.

• Noninvasive neuromodulation is advancing: TMS is FDA-cleared for depression, OCD, and smoking cessation; MRI-guided focused ultrasound is FDA-approved for tremor and is being explored for modulatory (non-ablative) applications and potential psychiatric targets.

• Closed-loop paradigms combining invasive recordings (e.g., stereo-EEG/DBS) with symptom or mood provocation can identify ‘craving/obsession’ signals (e.g., for binge eating) to personalize stimulation, while awareness-based therapies help many but often fail in the most severe, treatment-resistant cases.

Clinical Insight

Compulsive and impulsive disorders are circuit-based conditions of cortico–striatal–limbic networks; precise, and increasingly closed-loop, neuromodulation targeting the ventral striatum/nucleus accumbens can provide meaningful benefit for severe, treatment-resistant patients, while TMS offers an FDA-cleared, less invasive option for select indications.

Actionable Takeaway

Establish a referral pathway to a specialty center (functional neurosurgery/psychiatry) for patients with treatment-refractory OCD to discuss neuromodulation options—offer an FDA-cleared TMS trial first when available, and consider DBS or capsulotomy evaluation (or clinical trials) if nonresponsive.

25. The Human Upgrade: Biohacking for Longevity & Performance

Pandemic Fever Is BACK, Testosterone and Brain Tumors, Rabies, and Dog Flu : 1463

Published: 2026-05-08

URL: Listen Here

Summary

This episode synthesizes emerging signals in oncology and infectious disease: new data suggesting physiologic testosterone may restrain glioblastoma behavior, alongside multiple zoonotic threats (Influenza D, canine coronavirus HuPn-2018, Andes hantavirus) and a temporary disruption to U.S. rabies testing. The unifying message is proactive risk management—know patients’ biologic baselines (e.g., hormones), reinforce first-line defenses (mucosal immunity, sleep, stress), and act quickly when exposure windows are short (rabies, hantavirus).

Key Takeaways

• NIH-funded Cleveland Clinic research reported that low testosterone may drive glioblastoma stemness and invasion, whereas restoring physiologic testosterone reduced tumor growth by ~38% and improved survival in models—challenging assumptions that lower androgens universally reduce cancer risk.

• CDC has paused certain testing (including rabies), creating potential 1–2 week diagnostic delays; because rabies PEP is time-critical, suspected exposures warrant same-day ER initiation of prophylaxis without waiting for lab confirmation; ensure pets are vaccinated and consider pre-exposure prophylaxis when traveling to endemic regions.

• A U.S. Supreme Court one-week stay preserved telehealth access to mifepristone pending rapid review; the legal reasoning could set precedents affecting FDA authority, telehealth, and access to therapies such as compounded peptides and bioidentical hormones.

• University of Florida researchers highlighted two zoonotic risks: Influenza D circulating in U.S. cattle and a canine coronavirus (HuPn-2018) that has jumped to humans; no vaccines exist and population immunity is minimal—reassess raw milk risk and reduce close pet-lick exposure while strengthening mucosal immunity (sleep, stress control, vitamin D, zinc, fermented foods).

• Andes hantavirus cases linked to a cruise ship off the Canary Islands underscore that this American strain can spread person-to-person and causes severe pulmonary syndrome with high case fatality; recognize early symptoms (fever, myalgias, abrupt fatigue) and pursue urgent evaluation after plausible exposure.

Clinical Insight

Maintaining normal physiologic testosterone may suppress glioblastoma aggressiveness by limiting tumor stemness and invasion, suggesting clinicians should consider comprehensive hormonal assessment—especially in men—when evaluating brain tumor biology and overall oncologic risk, while recognizing these are emerging data that do not alone warrant changes to standard cancer therapy without oncology guidance.

Actionable Takeaway

For any patient with a credible rabies exposure (e.g., bat contact, wild carnivore bite), initiate post-exposure prophylaxis immediately and do not wait for laboratory confirmation—verify current turnaround times at your state lab and proactively counsel patients traveling to endemic regions about pre-exposure vaccination and prompt care-seeking.

26. Huberman Lab

Essentials: Compulsive Behaviors & Deep Brain Stimulation | Dr. Casey Halpern

Published: 2026-05-07

URL: Listen Here

Summary

This episode reviews how neurosurgical and noninvasive neuromodulation tools can modulate cortico–striatal–limbic circuits driving compulsive and impulsive behaviors, with a focus on OCD, addiction, and binge eating. It emphasizes current standards (SSRIs/tricyclics and ERP), the limitations of outcomes in severe, refractory cases, and the promise of symptom-locked, circuit-guided targeting—potentially enabling future noninvasive, scalable treatments.

Key Takeaways

• Deep brain stimulation (DBS) and MR-guided focused ultrasound (MRgFUS) can rapidly and powerfully modulate brain circuits; while established for tremor and Parkinson’s disease, these tools are being adapted to target limbic circuits implicated in compulsive and impulsive behaviors (e.g., OCD, addiction, binge eating).

• OCD is best understood along a spectrum; first-line treatments include SSRIs/tricyclics and exposure and response prevention (ERP), yet ~30% remain refractory. For severe cases, DBS or capsulotomy yield about a 50% responder rate, often with residual symptoms—highlighting the need for more precise, symptom-locked targeting.

• Compulsion and impulsivity share cortico-striatal-limbic circuitry (prefrontal/orbitofrontal cortex to basal ganglia/ventral striatum, especially nucleus accumbens) that gates reward seeking; identifying ‘craving/obsession-related’ neural signals intraoperatively and in lab paradigms is enabling symptom-specific neuromodulation.

• Noninvasive neuromodulation is expanding: TMS is FDA-approved for depression, OCD, and nicotine addiction; MRgFUS is FDA-approved for tremor and is being explored for circuit modulation and blood–brain barrier opening. Stereo-EEG methods from epilepsy are informing circuit mapping for psychiatric indications to guide future noninvasive targets.

• Improving patient awareness can help, but the most severe patients often remain refractory despite high awareness; combining rigorous circuit-guided neuromodulation with behavioral therapies and exploring AI/digital phenotyping to forecast high-risk states may provide scalable, clinically meaningful advances.

Clinical Insight

Compulsive and impulsive behaviors frequently arise from dysregulation within a shared cortico–striatal–limbic circuit—particularly the ventral striatum/nucleus accumbens—and targeted, symptom-linked neuromodulation (invasive now, potentially noninvasive later) can acutely alter these states, offering a path forward for patients with severe, treatment-resistant OCD and related conditions.

Actionable Takeaway

For patients with moderate-to-severe, treatment-resistant OCD (failed adequate SSRI/clomipramine trials and ERP), discuss risks/benefits and refer to a specialty center for consideration of neuromodulation—TMS (therapeutic and circuit-probing), DBS (e.g., ventral capsule/ventral striatum) or capsulotomy—and potential enrollment in circuit-mapping/SEEG-informed trials, while maintaining evidence-based behavioral therapy.

27. The Human Upgrade: Biohacking for Longevity & Performance

Pandemic Fever Is BACK, Testosterone and Brain Tumors, Rabies, and Dog Flu : 1463

Published: 2026-05-08

URL: Listen Here

Summary

This episode synthesizes timely health stories: a Cleveland Clinic/NIH report that normal testosterone may suppress glioblastoma stemness, a CDC testing pause that heightens urgency for immediate rabies PEP, legal moves affecting mifepristone telehealth access, and zoonotic threats from influenza D, canine coronavirus, and Andes hantavirus. The unifying theme is proactive risk management—optimizing hormonal and immune baselines and taking swift action after high-consequence exposures. Some details are host-reported and specific study links were not provided in-episode, which may limit independent verification.

Key Takeaways

• NIH-funded Cleveland Clinic research reported that physiologic testosterone suppresses glioblastoma stemness and invasion; in models, restoring normal T reduced tumor growth by ~38% and improved survival—challenging the assumption that lower testosterone uniformly lowers cancer risk.

• The CDC pause in rabies (and some other) testing is causing 1–2 week diagnostic delays; because post-exposure prophylaxis (PEP) must start promptly (≈10 days) and symptomatic rabies is nearly 100% fatal, suspected exposures warrant same-day ER care, with pets kept current on vaccines and travelers to endemic regions considering pre-exposure prophylaxis.

• A temporary U.S. Supreme Court stay preserved mail/telehealth access to mifepristone pending further action—raising broader implications for courts influencing FDA-approved protocols and telehealth access across other therapies (e.g., compounded peptides, bioidentical hormones).

• University of Florida researchers flagged two zoonotic risks: influenza D circulating in U.S. cattle and a canine coronavirus strain (CCoV-HuPn-2018) previously detected in humans; neither has established population immunity or vaccines, underscoring practical steps to bolster mucosal immunity and apply caution with raw milk and close pet contact (e.g., face-licking).

• An outbreak of Andes hantavirus linked to a cruise near the Canary Islands highlights that this strain can spread person-to-person and causes severe HPS with high mortality; early symptoms (fever, myalgias, rapid-onset fatigue) after plausible exposure should prompt urgent evaluation and explicit hantavirus consideration.

Clinical Insight

Emerging evidence suggests hypogonadism may promote glioblastoma aggressiveness via androgen receptor signaling; in appropriate male patients, clinicians should assess total and free testosterone and avoid non-indicated androgen deprivation—coordinating closely with oncology before modifying cancer-related hormonal management.

Actionable Takeaway

For suspected rabies exposures (e.g., bat contact/bites), initiate CDC-recommended post-exposure prophylaxis immediately without waiting for laboratory confirmation, given current testing delays and the near-100% fatality once symptoms begin.

28. Huberman Lab

Essentials: Understanding & Controlling Aggression

Published: 2026-05-14

URL: Listen Here

Summary

This episode explains the neural circuitry of aggression, emphasizing VMHvl Esr1+ neurons and how aromatized estrogen, stress hormones, and photoperiod interact to gate aggressive behaviors. It reframes testosterone’s role, highlights rapid circuit-level switches between mating and attack, and offers practical strategies—light exposure, heat, selective supplementation—to modulate aggression. As an Essentials recap, some dosing specifics and full trial details are referenced from prior episodes or literature rather than provided exhaustively in-audio.

Key Takeaways

• Aggression comprises distinct forms (reactive, proactive, indirect) and is generated by coordinated neural circuits—most critically estrogen receptor–expressing neurons in the ventromedial hypothalamus (VMHvl)—acting as fixed action patterns rather than isolated brain regions.

• Testosterone does not directly cause aggression; its aromatization to estrogen within the brain activates VMHvl Esr1+ neurons to drive attack behaviors in both males and females.

• Context strongly gates aggression: short photoperiods, elevated cortisol, and low serotonin increase the likelihood that estrogen will trigger aggression; long photoperiods (more daylight) mitigate this effect via changes in melatonin, dopamine, and stress hormones.

• Optogenetic activation of VMHvl Esr1+ neurons can rapidly switch behavior (e.g., from mating to attack) and recruits downstream periaqueductal gray (PAG) circuits that organize motor patterns such as biting and limb striking.

• Practical levers to reduce aggressive tendencies include lowering cortisol (morning sunlight exposure, sauna/hot baths; cautious, short-term ashwagandha) and, in ADHD, adjunct acetyl-L-carnitine has evidence for reducing aggressive/impulsive episodes in a randomized controlled trial.

Clinical Insight

Aggression propensity is a state-dependent output of hypothalamic circuits (VMHvl Esr1+), gated by steroid signaling and the stress–neurochemical milieu; assessing and modulating contextual factors—especially cortisol/photoperiod and serotonergic tone—can meaningfully alter aggressive behavior beyond simplistic attributions to testosterone or mood states.

Actionable Takeaway

Implement a structured morning light protocol for irritable or seasonally worsened aggression: advise 10–30 minutes of outdoor sunlight exposure within 1 hour of waking, daily for 2–4 weeks, to lower cortisol and shift neuromodulators toward reduced reactivity; reassess symptoms and add heat therapy (e.g., 20-minute sauna or hot bath sessions) as needed.

29. The Human Upgrade: Biohacking for Longevity & Performance

Semen Switch, Chewing Gum, Creatine Cheat, Cancer Plants, and Bedtime Risk : 1467

Published: 2026-05-15

URL: Listen Here

Summary

This episode reviews studies on creatine’s cognitive support under acute sleep loss, microplastic exposure from chewing gum, the cardiovascular risks of irregular bedtimes, plant alkaloid biosynthesis enabling anticancer drug discovery, and a reversible nonhormonal male contraceptive target. The unifying theme is that seemingly neutral habits or exposures can carry measurable biological effects, with particular clinical relevance for circadian consistency. Limitations: the transcript lacks formal citations and may contain transcription errors in compound or organism names; verify primary sources before changing practice.

Key Takeaways

• A single moderate dose of creatine (~14 g) preserved up to ~12% more cognitive performance during 21 hours of sleep deprivation in a double-blind crossover trial; women and people with lower baseline brain creatine (e.g., vegetarians/vegans) appeared to benefit more.

• Chewing gum (synthetic and products marketed as natural/plastic-free) shed hundreds to ~3,000 microplastic fragments per stick into saliva; detected polymers included polyethylene and polystyrene, highlighting a previously underrecognized exposure source.

• Objectively measured irregular bedtimes combined with shorter sleep were associated with about double the risk of major cardiovascular events over a decade in a Finnish cohort, underscoring the clinical importance of sleep timing regularity.

• UBC researchers mapped a chromosome-level genome and decoded the biosynthetic pathway for a rare spirooxindole alkaloid (Mitraphylene) implicated in anti-tumor and anti-inflammatory activity, enabling potential scalable bioproduction; this is an early-stage drug discovery lead, not a recommendation to use kratom or related supplements.

• Cornell researchers demonstrated reversible, nonhormonal male contraception in mice by inhibiting the testis-specific protein BRDT with JQ1: spermatogenesis stopped during treatment and fertility recovered after cessation with healthy offspring; translational safety and long-term effects require further study.

Clinical Insight

Sleep regularity—not just duration—is a modifiable risk factor linked to major cardiovascular events; counseling patients to maintain consistent bedtimes should be incorporated into cardiovascular risk reduction strategies.

Actionable Takeaway

Ask patients to set and adhere to a fixed 90-minute bedtime window every day (including weekends) and reassess sleep timing variability after 4–8 weeks; for higher-risk individuals, consider actigraphy or validated wearable data to quantify and address irregularity.

30. The Human Upgrade: Biohacking for Longevity & Performance

Semen Switch, Chewing Gum, Creatine Cheat, Cancer Plants, and Bedtime Risk : 1467

Published: 2026-05-15

URL: Listen Here

Summary

This episode reviews new research spanning acute creatine use for sleep-deprivation resilience, unrecognized microplastic exposure from chewing gum, the cardiovascular risks of irregular sleep timing, plant-derived drug discovery via kratom alkaloid biosynthesis, and a reversible, non-hormonal target for male contraception. The themes emphasize measurable exposures and behaviors that affect health now (e.g., sleep regularity, microplastics) and pipeline advances likely to influence future oncology and reproductive therapeutics.

Key Takeaways

• Acute creatine supplementation (~10–15 g monohydrate) preserved up to ~12% more cognitive performance during 21 hours of sleep deprivation in a double-blind crossover trial; benefits appeared greater in women and those with lower baseline brain creatine (e.g., vegetarians/vegans).

• Chewing gum—both synthetic and products marketed as “natural” or “plastic-free”—shed hundreds to ~3,000 microplastic fragments per stick into saliva during chewing, adding a largely unrecognized exposure source.

• Objectively measured irregular bedtimes combined with short sleep duration were associated with approximately double the risk of major cardiovascular events over a decade, underscoring circadian regularity as a modifiable risk factor.

• UBC researchers mapped the genome of Mitragyna parvifolia and decoded the biosynthetic pathway for the alkaloid mitraphylline, enabling potential bioreactor-scale production; this is a drug discovery pipeline advance, not evidence that kratom treats cancer.

• Pharmacologic inhibition of the testis-specific protein BRDT with JQ1 in mice produced a reversible, non-hormonal “on–off” switch for spermatogenesis, restoring fertility after treatment cessation and suggesting a viable target for male contraception.

Clinical Insight

Sleep timing regularity is an independent, modifiable cardiovascular risk factor: patients with highly irregular bedtimes and short sleep had roughly double the rate of major cardiovascular events when sleep timing was objectively measured, supporting routine assessment and counseling on circadian consistency.

Actionable Takeaway

Incorporate a brief sleep-timing screen (e.g., ask about bedtime variability and weekend ‘social jetlag’) and counsel patients to maintain a consistent 90-minute bedtime window across all days, including weekends, as part of cardiovascular risk reduction.

31. Huberman Lab

How to Overcome Social Anxiety | Dr. Nick Epley

Published: 2026-05-18

URL: Listen Here

Summary

Evidence converges that small, authentic social exchanges meaningfully improve mental and physical well-being. Social anxiety is best treated with real-world exposure that recalibrates overly pessimistic beliefs about others. Voice and in-person modalities humanize and increase perceived intelligence relative to text, suggesting clinicians and clients should favor voice/in-person touchpoints when feasible.

Key Takeaways

• Real-world social exposure—not simulation—reduces social anxiety by updating inaccurate predictions about rejection; people are helped and accepted more often than they expect.

• Brief, everyday interactions (greetings, small talk, sincere compliments) reliably lift mood; the biggest well-being gain comes from moving from no contact to some contact.

• Voice conveys rich mental-state cues that humanize others; compared with text, speaking increases perceived intelligence and mutual understanding, especially across divides.

• We routinely misread others due to cognitive biases (egocentrism, stereotyping, correspondence bias); testing assumptions through low-stakes bids to connect corrects many misinferences.

• Short periods of acting more extraverted increase positive affect for most people, including introverts; small, repeated real interactions function as effective ‘social prescriptions’.

Clinical Insight

Loneliness and social isolation are modifiable risk factors linked to increased all-cause mortality, cardiometabolic burden, and dysregulated stress physiology. For social anxiety, graded in vivo exposure is an evidence-based intervention that changes maladaptive social predictions (e.g., overestimating rejection) rather than merely dampening arousal.

Actionable Takeaway

Implement a 2-week graded social exposure plan: daily, initiate one brief, real interaction (e.g., greet a neighbor or cashier, ask a small favor, offer a sincere compliment); log predicted outcome vs. actual outcome to capture expectancy violations. Each week, add 2–3 short voice calls (not texts) to trusted contacts. Progressively increase depth or duration as mispredictions correct.

32. Huberman Lab

How to Overcome Social Anxiety | Dr. Nick Epley

Published: 2026-05-18

URL: Listen Here

Summary

Dr. Nick Epley discusses how everyday social connections—especially those using richer cues like voice and eye contact—improve mental and physical health, and how misbeliefs about others’ interest create avoidant behavior and social anxiety. He outlines evidence that real-world exposure updates these misbeliefs, highlights the health costs of isolation, and offers practical ways to cultivate frequent, small interactions that enhance well-being.

Key Takeaways

• Real-world exposure (not simulation) is the most effective way to reduce social anxiety because it updates mistaken beliefs about rejection and others’ responses.

• People reliably underestimate how much others want to engage and help; silence and phone use are often misread as disinterest, leading to missed opportunities for connection.

• Richer communication channels—especially voice (and eyes/visual behavior when available)—convey the ‘presence of mind,’ reduce dehumanization, and improve mutual understanding compared with text-only exchanges.

• Small, daily social interactions (brief greetings, compliments, short conversations) measurably improve mood and health; moving from no contact to some contact yields the biggest well-being gains.

• Acting more extroverted (within one’s comfort) increases positive affect across the introversion–extroversion spectrum; building simple, repeatable social habits is key.

Clinical Insight

For patients with social anxiety, the core therapeutic lever is belief change achieved through graded, in vivo exposure to real social interactions—patients learn (through experience) that positive or neutral responses are far more common than anticipated, which reduces avoidance and improves functioning.

Actionable Takeaway

Prescribe a graded real-world exposure plan: ask the patient to complete one brief, low-stakes social action daily (e.g., greet a stranger, ask for minor help, offer a sincere compliment), log the outcome, and review weekly to challenge overestimated rejection fears and reinforce corrective learning.

33. The Human Upgrade: Biohacking for Longevity & Performance

The Biblical Anti-Aging Fruit That Scientists Are Obsessed With : 1470

Published: 2026-05-21

URL: Listen Here

Summary

This episode details the discovery-to-clinic journey of urolithin A (Mitopure) as a nutritional mitophagy activator that enhances mitochondrial function, with human data showing improved immune cell composition and mitochondrial gene expression after 4 weeks and topical studies demonstrating better collagen signaling and wrinkle reduction. It provides dosing guidance and highlights the limitations of pomegranate-derived precursors, underscoring UA’s relevance for clinicians integrating mitochondrial-targeted interventions into healthy aging care.

Key Takeaways

• Urolithin A (Mitopure), a gut-derived postbiotic from pomegranate ellagitannins, activates mitophagy and improves mitochondrial function; preclinical work showed ~45% lifespan extension in C. elegans and ~40% endurance gains in aged mice.

• In a human study (Nature Aging), adults aged 50–70 taking 1 g/day for 4 weeks had increased naïve CD8 T cells and NK cells, decreased inflammation, and upregulated mitochondrial gene expression/function in immune cells.

• Muscle biopsy studies show increased expression of mitochondrial genes after 4 weeks of oral urolithin A at 500–1,000 mg/day, helping define an effective daily dose (≥500 mg) for clinical use.

• Topical urolithin A improved skin biology and appearance: increased collagen-related gene expression, >10% reduction in UV-induced inflammation, and statistically significant wrinkle reduction by 8 weeks (signals as early as 2 weeks).

• Only ~30–40% of people can convert pomegranate polyphenols into urolithin A; direct UA supplementation provides reliable exposure versus juice/extracts (which also add sugar/oxalates).

Clinical Insight

Urolithin A is an evidence-based mitophagy activator with early clinical signals in muscle and immune aging; consistent supplementation (≥500 mg/day) can improve mitochondrial-related biomarkers and immune cell profiles in midlife and older adults, offering a practical adjunct for healthy aging strategies.

Actionable Takeaway

For eligible adults focused on longevity or mitochondrial health, consider urolithin A 500 mg daily (up to 1,000 mg) taken consistently for 2–4 months before assessing response; avoid relying on pomegranate extracts due to variable microbiome conversion, and optionally pair with topical UA for skin benefits.

34. The Human Upgrade: Biohacking for Longevity & Performance

The Biblical Anti-Aging Fruit That Scientists Are Obsessed With : 1470

Published: 2026-05-21

URL: Listen Here

Summary

This episode details the discovery-to-clinic journey of urolithin A as a mitophagy activator that targets a root mechanism of aging: mitochondrial dysfunction. The discussion reviews preclinical and human data showing improvements in muscle mitochondrial gene expression, immune cell composition, and topical skin outcomes, positioning urolithin A as a practical, evidence-supported addition to longevity care. (Note: Some study specifics were summarized at a high level in the transcript and may lack full methodological details.)

Key Takeaways

• Urolithin A (commercialized as Mitopure/Timeline) is a postbiotic derived from pomegranate ellagitannins via gut microbes; only ~30–40% of people naturally convert, so a standardized supplement ensures reliable delivery at effective doses.

• Mechanism of action is mitophagy activation (selective recycling of dysfunctional mitochondria), with preclinical data showing ~45% lifespan extension in C. elegans and ~40% greater running endurance in aged mice.

• Human data: 4 weeks of 500 mg–1 g/day increased mitochondrial gene expression in skeletal muscle biopsies; clinical benefits are most apparent with consistent daily use over 2–4 months.

• Immune health (Nature Aging study): adults aged 50–70 taking 1 g/day for 1 month had increased naive CD8 T cells and NK cells and reduced inflammatory signaling.

• Topical urolithin A increased collagen-related gene expression, reduced post-UV skin inflammation (~10%), and produced statistically significant reductions in fine lines/wrinkles by 8 weeks; L’Oréal is collaborating to incorporate the ingredient based on shared research.

Clinical Insight

Standardized urolithin A is a clinically investigated mitophagy activator that can improve mitochondrial biomarkers and favorably shift immune cell populations in older adults within weeks, supporting its use as a safe, adjunctive tool to enhance healthspan beyond traditional approaches (e.g., NAD precursors, rapamycin).

Actionable Takeaway

For adults over ~50, consider a monitored 8–12 week trial of urolithin A at 500–1000 mg orally once daily; track patient-reported energy/exercise tolerance and optionally inflammation markers (e.g., CRP) or simple functional tests, and avoid substituting pomegranate extract due to variable microbiome conversion.

35. Huberman Lab

Build Muscle, Great Posture & Resilience to Injury | Jeff Cavaliere

Published: 2026-05-25

URL: Listen Here

Summary

This episode emphasizes that “small” accessory work—especially for the glute medius, rotator cuff, neck, grip, and feet—makes the big lifts possible for decades by preventing pain and improving function. Cavaliere outlines practical screens (e.g., old‑man shoe/sock test) and brief, low‑equipment drills that clinicians and trainees can integrate alongside flexible programming and sensible nutrition to support long‑term health, performance, and injury resilience.

Key Takeaways

• Small, often-neglected muscles and motor control (glute medius, rotator cuff, neck flexors/extensors, foot intrinsics) are foundational for pain-free longevity and enable progress on the big compound lifts.

• A large share of nonsurgical low back pain reflects gluteal weakness and pelvic control deficits (e.g., Trendelenburg pattern) rather than spine pathology; targeted work (reverse hypers, wall ‘hip hike,’ banded hip rotation) can resolve symptoms and prevent recurrence.

• Medial elbow pain during pulling is frequently a grip/hand position issue (overloading ring/pinky at the fingertips); using a knuckles-over-bar grip and loading the meat of the hand often eliminates symptoms.

• Shoulder durability depends on external rotator strength and posture—train banded external rotation with the elbow pinned (towel cue), use face pulls, and avoid chronically elevated, internally rotated positions.

• Programming principles: take safer/isolation movements to (or near) failure, avoid true failure on complex lifts, count indirect volume (e.g., biceps on back day), and use flexible scheduling (even ‘split the split’) rather than forcing a 7‑day template; pair with simple daily/weekly function tests (old‑man shoe/sock test, side‑plank with top-leg abduction) and sensible ‘clean omnivore’ nutrition.

Clinical Insight

For many patients with common musculoskeletal complaints (e.g., nonspecific low back pain, shoulder impingement symptoms, medial elbow pain), the primary driver is often weakness or poor motor control in adjacent or distal links of the kinetic chain (glute medius/pelvic control, rotator cuff external rotators, grip mechanics) rather than structural pathology—prioritizing targeted strengthening and technique cues can reduce pain, restore function, and decrease unnecessary imaging or surgical referrals.

Actionable Takeaway

For chronic, nonspecific low back pain, screen glute medius function (single‑leg stance/Trendelenburg sign) and prescribe a 5–7 minute, 3x/week accessory routine: wall ‘hip hike’/abduction (2–3 sets/side) plus reverse hypers or prone hip extension with a brief hold at peak contraction (2–3 sets). Reassess gait and pain after 2–4 weeks and progress to banded hip ER/IR as tolerated.

36. Huberman Lab

Essentials: The Science & Process of Healing from Grief

Published: 2026-05-28

URL: Listen Here

Summary

This episode reframes grief as a neurobiological remapping process across space, time, and closeness, emphasizing that yearning arises from motivation circuits rather than depression per se. It offers practical, physiology-informed tools—structured grieving sessions, vagal tone enhancement, and sleep/cortisol stabilization—to support adaptive progression through grief and reduce risk of complicated grief. Some imaging findings and animal-to-human links were discussed without full study citations in the episode.

Key Takeaways

• The brain maps relationships across three braided dimensions—space, time, and closeness—and grief is the neuroplastic remapping that uncouples space/time predictions from an intact sense of attachment.

• fMRI work highlights the inferior parietal lobule as a common code for physical distance, temporal spacing, and social closeness, while motivation/“yearning” circuits (e.g., nucleus accumbens) are prominently engaged in grief.

• Individual differences in oxytocin signaling—particularly receptor density within reward/motivation circuits—help explain variability in the intensity and persistence of yearning during grief.

• The Kübler-Ross stages are not universal; grief and depression share symptoms but are distinct processes with different neurobiological underpinnings.

• Structured “rational grieving” (time-limited sessions that fully feel attachment while avoiding counterfactual thinking), supported by physiologic tools (enhancing vagal tone, stabilizing diurnal cortisol via morning light, prioritizing sleep/NSDR), promotes adaptive grieving and may reduce risk for complicated grief.

Clinical Insight

Effective grieving preserves the felt attachment while deliberately remapping space and time predictions; interventions that enhance vagal tone and normalize diurnal cortisol can facilitate this adaptive neuroplastic transition and help prevent complicated grief.

Actionable Takeaway

Schedule a daily 10–20 minute “rational grieving” session: intentionally feel your attachment to the deceased while actively avoiding counterfactual (“what if”) thoughts; before starting, perform 2–3 minutes of slow, exhale-emphasized breathing to increase vagal tone and stability during the session.

37. Huberman Lab

Peptides: The Science, Uses & Safety | Dr. Abud Bakri

Published: 2026-06-01

URL: Listen Here

Summary

The discussion frames peptides by receptor biology and evidence strength. Trial-backed metabolic peptides (GLP-1/GIP) contrast with research-stage compounds (e.g., BPC-157, thymic/epigenetic peptides) that lack rigorous human data. Emphasis is on clinical guardrails: verified sourcing, slow titration where applicable, and objective monitoring for efficacy and safety.

Key Takeaways

• Prioritize peptides with defined receptors and robust human data (e.g., GLP-1 agonists); treat others with limited evidence (e.g., BPC-157, TB-4/Thymosin-β4, epithalon) as experimental.

• BPC-157 shows promising animal data for GI and tissue repair but lacks high-quality human trials; safety, sourcing, and regulatory status are major concerns.

• GLP-1/GIP agents (e.g., semaglutide, tirzepatide) deliver substantial, trial-proven weight and metabolic benefits when titrated slowly and paired with lifestyle support.

• Thymic peptides and GH secretagogues may influence immune/body composition markers but require careful monitoring (e.g., IGF-1, glucose/insulin sensitivity) and medical oversight.

• Quality control and legality matter: avoid gray-market products; verify compounding/pharmacy sources and monitor objective biomarkers.

Clinical Insight

Think pharmacology-first: confirm target, mechanism, human outcomes, and safety monitoring before considering any peptide, and avoid non-verified supply chains.

Actionable Takeaway

If using a GLP-1 agonist for weight management, start at the lowest dose, titrate every ~4 weeks as tolerated, maintain nutrition/resistance training, and monitor GI tolerance, hydration, and mood—under clinician supervision with pharmacy-verified products.

38. The Human Upgrade: Biohacking for Longevity & Performance

Putin Longevity, Pancreatic Cancer Cure, AI Therapy, GLP-1 Breast Cancer... : 1479

Published: 2026-06-05

URL: Listen Here

Summary

This episode reviews emerging fronts in cancer and longevity—from oncolytic viruses in pancreatic cancer and the potential cancer‑risk impact of GLP‑1 RAs, to the superior long‑term evidence for sauna versus cold exposure—while cautioning against adolescents’ reliance on AI chatbots for mental health. It also flags Russia’s large‑scale state investment in longevity technologies and its implications for global science. Limitations: several findings are preliminary or observational, and some sources were not formally cited in the episode.

Key Takeaways

• An early safety study injecting an engineered oncolytic virus directly into pancreatic tumors (n=3) showed intratumoral replication, tumor cell lysis, and apparent immune activation even at low dose—suggesting feasibility in a treatment‑resistant cancer.

• Survey data indicate ~19% of adolescents and young adults turn to AI chatbots when distressed (highest in ages 18–21), raising concern about dependency and delayed access to human mental health care.

• A Penn Medicine retrospective cohort (>111,000 women, ages 45–80, BMI ≥25) found GLP‑1 receptor agonist exposure associated with ~30–35% lower odds of breast cancer; while observational, authors call for randomized trials and mechanisms may include improved insulin resistance and reduced inflammation.

• Sauna use has robust long‑term human data linking higher frequency (≥4 sessions/week) to lower cardiovascular and all‑cause mortality; by contrast, cold exposure shows acute benefits with limited long‑term human outcomes despite mechanistic interest (e.g., RBM3).

• The Wall Street Journal reports Russia’s ~$26B state longevity program (gene therapy, bioprinting, xenotransplantation) led by Maria Vorontsova and Mikhail Kovalchuk, highlighting potential scientific advances and concerns about data openness.

Clinical Insight

Addressing metabolic dysfunction (insulin resistance, chronic inflammation) may meaningfully reduce cancer risk—illustrated by observational data linking GLP‑1 RA use to lower breast cancer incidence—supporting integration of metabolic optimization into preventive and oncologic care while awaiting randomized trials.

Actionable Takeaway

When appropriate, counsel patients to incorporate regular sauna bathing as a longevity and cardiovascular risk‑reduction modality (e.g., ~4 sessions/week, 15–20 minutes at typical Finnish sauna temperatures), after screening for contraindications such as unstable cardiovascular disease, hypotension, dehydration, pregnancy, or heat intolerance.

39. The Human Upgrade: Biohacking for Longevity & Performance

Putin Longevity, Pancreatic Cancer Cure, AI Therapy, GLP-1 Breast Cancer... : 1479

Published: 2026-06-05

URL: Listen Here

Summary

This episode reviews emerging signals in oncology and longevity: early oncolytic virus results in pancreatic cancer, observational evidence linking GLP-1 use to lower breast cancer odds, and the strategic expansion of state-level longevity R&D in Russia. It also contrasts robust longitudinal data favoring frequent sauna use for longevity with the more limited human evidence base for cold exposure, and highlights risks of adolescents relying on AI chatbots for mental health support.

Key Takeaways

• Early safety-dose intratumoral oncolytic virus therapy in pancreatic cancer reportedly induced tumor cell lysis and immune activation in three patients, suggesting a promising mechanism in a notoriously resistant malignancy.

• Roughly 19% of adolescents and young adults report using AI chatbots for emotional support; while perceived as helpful, this may foster dependence and delay access to human-delivered mental health care.

• A Penn Medicine retrospective cohort of ~111,000 women (ages 45–80; BMI ≥25) found GLP-1 receptor agonist exposure associated with ~30–35% lower odds of breast cancer versus non-users; causality is unproven and trials are needed.

• Russia is reportedly launching a $26B state-backed anti-aging initiative (gene therapy, organ bioprinting, xenotransplantation), signaling accelerating investment in longevity science but raising concerns about data openness.

• Long-term Finnish data link frequent sauna use (≥4 sessions/week) to lower cardiovascular and all-cause mortality; cold exposure offers acute benefits but lacks comparable long-term human outcomes data for longevity.

Clinical Insight

Optimizing metabolic health remains central to preventive oncology: observational data suggest GLP-1 receptor agonists may reduce breast cancer risk alongside benefits in weight, insulin resistance, and inflammation, but clinicians should interpret this as hypothesis-generating until randomized trials confirm causality.

Actionable Takeaway

For patients without contraindications, recommend regular sauna use as a primary longevity modality (target ≥4 sessions/week as tolerated) to support cardiovascular risk reduction and overall mortality benefits, with counseling on hydration, blood pressure monitoring, and heat safety.

40. The Human Upgrade: Biohacking for Longevity & Performance

Putin Longevity, Pancreatic Cancer Cure, AI Therapy, GLP-1 Breast Cancer... : 1479

Published: 2026-06-05

URL: Listen Here

Summary

This episode spotlights emerging and established interventions across oncology, mental health, and longevity: early oncolytic virotherapy signals in pancreatic cancer, observational data linking GLP-1 use to lower breast cancer incidence, and strong evidence favoring regular sauna for mortality risk reduction over cold plunges for longevity. It also flags rising youth reliance on AI chatbots for emotional support and Russia’s state-scale investment in anti-aging technologies, underscoring opportunities and cautions for clinicians navigating fast-moving health innovations.

Key Takeaways

• A first-in-human safety study injecting an engineered oncolytic virus directly into pancreatic tumors (n=3) showed intratumoral replication, tumor cell lysis, and an immune response even at low dose—an encouraging signal in a notoriously treatment-resistant cancer.

• About 19% of adolescents and young adults report turning to AI chatbots for emotional support, with highest use in ages 18–21; hosts caution that chatbot engagement may foster dependency and delay access to real clinical care.

• A large Penn Medicine retrospective cohort (~111,000 women, ages 45–80, BMI ≥25) found GLP-1 receptor agonist exposure associated with ~30–35% lower odds of breast cancer versus non-use; observational design precludes causality but aligns with metabolic risk-reduction mechanisms.

• Russia reportedly launched a ~$26B state-backed longevity initiative (gene therapy, xenotransplantation, organ bioprinting), signaling sovereign-scale investment in anti-aging science but raising concerns about openness and data sharing.

• Sauna use has robust long-term human data linking higher frequency (≥4 sessions/week) to reductions in cardiovascular and all-cause mortality, whereas cold plunges show mainly acute benefits (alertness, soreness, mood) with limited human longevity outcomes to date.

Clinical Insight

Improving metabolic health may meaningfully influence cancer risk: a large observational analysis suggests GLP-1 receptor agonist use in overweight/obese midlife-to-older women correlates with substantially lower breast cancer incidence, reinforcing metabolic dysfunction as an actionable cancer risk pathway and warranting randomized trials.

Actionable Takeaway

For appropriate patients without contraindications, recommend regular sauna bathing as a primary longevity modality—aim for four or more sessions per week—while using cold exposure chiefly for acute performance/recovery rather than long-term longevity benefits.

41. Health Longevity Secrets

The Smart Toilet That Could Detect Cancer Before You Know You Have It

Published: 2026-06-09

URL: Listen Here

Summary

This episode presents an AI-powered smart toilet that continuously quantifies stool and urine characteristics to deliver actionable gut and urinary insights at home. The approach aims to complement clinical care by improving adherence-free monitoring, identifying behavior and diet-related triggers, and potentially enabling earlier colorectal cancer detection through trend analysis, all while addressing privacy, validation, and behavior-change coaching.

Key Takeaways

• An AI-enabled smart toilet (Throne Science) uses a down-facing camera and microphone to passively and continuously measure stool morphology (e.g., Bristol Stool Scale, color, volume, timing), hydration (urine color/clarity), bathroom habits (time to first evacuation, total sitting time), and urinary flow (acoustic uroflowmetry).

• Trend-level detection of fecal occult blood across many bowel movements could act as a ‘smoke detector’ for colorectal cancer (CRC), potentially improving signal-to-noise over single-time tests by distinguishing transient bleeding (e.g., hemorrhoids) from a monotonic rise more suggestive of neoplasia.

• CRC incidence is rising in younger adults and is now a leading cause of cancer death under age 50; most deaths reflect late-stage diagnosis despite a 7–10 year polyp-to-cancer window that makes early detection and referral highly impactful.

• Bathroom behavior matters: prolonged sitting on the toilet—often driven by smartphone use—has been associated with higher hemorrhoid risk; time-based nudges (e.g., <10 minutes) may mitigate risk.

• Objective, longitudinal bathroom data can reveal personalized triggers (diet, stress, sleep, travel) and may outperform patient recall for IBS/IBD monitoring; early validation efforts (e.g., DDW abstract, academic partnerships) aim to align AI outputs with clinical standards.

Clinical Insight

Continuous, passive, objective bathroom-derived metrics can augment clinical decision-making—especially for earlier CRC detection (via repeated occult blood trend analysis) and for IBS/IBD management (reliable frequency/consistency and timing)—reducing reliance on inaccurate patient recall and enabling timelier specialist referral.

Actionable Takeaway

Add a 60-second ‘bowel and bladder check’ to routine visits: ask about rectal bleeding, stool form/frequency, and time spent on the toilet; for average‑risk adults aged 45–75, order annual FIT per USPSTF and counsel limiting toilet time to ≤10 minutes and avoiding smartphone use to reduce hemorrhoid risk.

42. The Human Upgrade: Biohacking for Longevity & Performance

The Foods That Starve Cancer | William Li : 1481

Published: 2026-06-09

URL: Listen Here

Summary

Dr. William Li discusses how foods can ‘starve’ cancers by modulating angiogenesis, emphasizing that vascular balance—not blanket inhibition—is key. He links longevity to superior vascular, immune, and metabolic function, highlights practical tracking tools (PWV, FMD, HRV), and warns that microplastics in human tissues correlate with inflammation and increased cardiovascular events—making exposure reduction and endothelial health support clinically relevant.

Key Takeaways

• Diet can modulate angiogenesis: in blinded lab assays, roughly half of food extracts tested were as potent as anti-cancer drugs at inhibiting angiogenesis, supporting a biologically plausible role for food in tumor microenvironment control.

• Angiogenesis is a balanced, homeostatic system; the goal is not chronic inhibition but keeping vascular growth and inhibition in physiological equilibrium—context matters (e.g., tumors vs. tissue repair).

• Longevity insights from centenarians suggest superior immune, metabolic, gut, and vascular health; genetics and lifestyle each contribute substantially, making longitudinal, personalized tracking (HRV, VO2 max, inflammatory markers) more actionable than one-off tests.

• Microplastics are being detected in human tissues (arterial plaques, brain) and correlate with higher inflammatory biomarkers and markedly higher rates of cardiovascular events; major exposure routes include inhalation (notably tire-wear particles) and ingestion (packaging, some chewing gums).

• Clinically useful vascular metrics—flow-mediated dilation (FMD) and pulse wave velocity (PWV)—offer practical ways to track endothelial resilience and biological aging; stress-modulating strategies (vagus nerve stimulation, breathwork) and mitochondrial health support overall resilience.

Clinical Insight

Vascular health is a highly modifiable, central driver of longevity and disease risk; integrating anti-angiogenic dietary patterns, stress-autonomic regulation, and objective vascular metrics (e.g., PWV/FMD) can materially improve outcomes while identifying emerging risks such as microplastic-associated inflammation.

Actionable Takeaway

Begin trending pulse wave velocity (PWV) for midlife and older patients—obtain a baseline with a validated device and reassess quarterly—and use results to guide endothelial-supportive interventions (sleep, exercise, diet, stress reduction) while counseling on microplastic exposure reduction (less plastic-packaged foods/chewing gum, improve indoor air filtration near traffic).

43. The Human Upgrade: Biohacking for Longevity & Performance

The Foods That Starve Cancer | William Li : 1481

Published: 2026-06-09

URL: Listen Here

Summary

Dr. William Li discusses how diet can influence cancer via angiogenesis, framing vascular growth as a balanced, homeostatic system while advocating for personalized, longitudinal biomarker tracking to extend healthspan. He also highlights emerging evidence that inhaled and ingested microplastics embed in atherosclerotic plaques and brain tissue, correlate with inflammation, and predict substantially higher cardiovascular event rates—making exposure reduction and vascular monitoring immediate priorities.

Key Takeaways

• In rigorous angiogenesis assays, about half of tested whole-food extracts equaled or outperformed anti-angiogenic cancer drugs, supporting a biologically plausible role for diet in modulating tumor blood supply.

• Angiogenesis is a homeostatic system: endogenous growth factors and inhibitors act like a dial, so the clinical goal is physiologic balance (not blanket inhibition) to support vascular health, muscle growth, tissue repair—and to avoid feeding tumors.

• Longevity insights from centenarians/super‑centenarians point to stronger immunity, lower inflammation, healthier metabolism, gut, and vasculature; genetics and lifestyle each contribute substantially (~50/50), with stress resilience (e.g., vagus‑nerve engagement, HRV) as a key modifiable factor.

• Vascular resilience is measurable and trainable; tracking pulse wave velocity (PWV), HRV, VO2 max, temperature shifts, and (where available) flow‑mediated dilation (FMD) can guide personalized prevention and course‑corrections over time.

• Microplastics are an emerging cardiovascular and neuro risk: major exposure is via inhalation (e.g., tire‑wear particles) and ingestion (packaging, some gums); particles have been found in carotid plaques and brain tissue and are associated with higher inflammatory markers and ~4× higher 3‑year risk of MI/stroke/death.

Clinical Insight

Environmental microplastic burden has clinically meaningful cardiovascular implications—plaque-embedded microplastics correlate with systemic inflammation and markedly higher major adverse cardiovascular events—so clinicians should pair exposure‑reduction counseling with aggressive vascular risk management and longitudinal vascular function monitoring.

Actionable Takeaway

Incorporate pulse wave velocity (PWV) into routine risk assessment and trend it over time; if elevated, intensify LDL and blood‑pressure targets and aerobic training, and counsel on microplastic reduction (use HEPA air filtration and high‑grade cabin filters, minimize plastic‑packaged ultra‑processed foods, and avoid plastic‑containing chewing gum).

44. Huberman Lab

Essentials: Sleep Toolkit for Optimizing Sleep & Sleep-Wake Timing

Published: 2026-06-11

URL: Listen Here

Summary

This episode presents an evidence-informed sleep toolkit centered on light, temperature, movement, caffeine/food timing, and evening environment to align circadian biology and enhance sleep. It outlines three daily ‘critical periods’ with specific do’s/don’ts, and offers an optional, conservative supplement stack if behavioral measures are insufficient. Practical guidance on naps, late-day exercise, red light at night, and phase-shifting via the temperature-minimum framework makes the protocol applicable to general patients, shift workers, and travelers.

Key Takeaways

• Morning sunlight viewing within 30–60 minutes of waking is the primary zeitgeber to set the cortisol peak, anchor circadian rhythms, and improve nighttime sleep; aim for ~5 minutes on clear days, ~10 minutes with some clouds, and 20–30 minutes when heavily overcast; do it outdoors (not through windows) and avoid sunglasses while never staring at the sun.

• Use temperature and movement strategically: brief cold exposure (1–3 minutes) and/or exercise early in the day raise core temperature and alertness, whereas a warm bath/sauna 1–2 hours before bed facilitates the necessary drop in core temperature to initiate sleep; keep the sleep environment cool.

• Caffeine timing matters: delaying caffeine 90–120 minutes after waking can smooth daytime energy; limit to ≤100 mg after 4 p.m. to protect sleep architecture; large early meals increase sleepiness by diverting resources to digestion, while early eating can advance alertness via metabolic cues.

• Structure the day around three critical periods: (1) first 0–3 hours after waking (light, temperature, movement, prudent caffeine/food timing); (2) afternoon/evening (optional short nap/NSDR, avoid excess caffeine, recognize that intense late exercise delays the clock, get late-afternoon/evening sunlight to ‘inoculate’ against nocturnal light); (3) late evening/night (minimize artificial light—especially overhead—between ~10 p.m.–4 a.m., cool room, avoid alcohol/THC for better sleep architecture).

• If behavioral tools are insufficient, a sleep supplement ‘stack’ taken 30–60 minutes before bed—magnesium threonate (~145 mg), apigenin (50 mg), and theanine (100–400 mg)—can help some individuals; watch for GI upset with magnesium and vivid dreams with theanine; routine melatonin use (especially in children) is discouraged due to supraphysiologic dosing and endocrine effects.

Clinical Insight

Light timing—specifically obtaining morning and late-afternoon/evening outdoor light while minimizing nocturnal artificial light—is the most potent, low-risk lever for entraining circadian rhythm and improving sleep quality, and should be a first-line behavioral intervention for patients with sleep complaints.

Actionable Takeaway

Advise patients to get outside within 30–60 minutes of waking and expose their eyes to natural daylight (without sunglasses, never staring at the sun) for ~5 minutes on clear days, ~10 minutes if cloudy, and 20–30 minutes if heavily overcast; repeat a shorter outdoor light exposure in late afternoon/early evening, then minimize artificial light—especially overhead—after sunset.

45. The Human Upgrade: Biohacking for Longevity & Performance

Brain Fog, Memory Loss, and Alzheimer’s Prevention | Dr. Majid Fotuhi : 1482

Published: 2026-06-11

URL: Listen Here

Summary

Dr. Majid Fotuhi outlines a practical, evidence‑informed framework for preventing and reversing brain fog and reducing Alzheimer’s risk by targeting five lifestyle pillars and whole‑body contributors. He emphasizes that hippocampal volume and cognition are plastic and modifiable—regardless of APOE4 status—highlighting VO2 max, sleep quality, B12 sufficiency, stress control, and social connection as high‑yield levers for brain longevity.

Key Takeaways

• Late‑life cognitive decline and brain fog are usually multifactorial and modifiable; most Alzheimer’s cases involve mixed pathologies (inflammation, vascular insufficiency, impaired glymphatic ‘rinsing,’ and protein aggregates), so addressing multiple contributors improves outcomes.

• Five pillars—exercise, optimal sleep, healthy nutrition, stress reduction, and cognitively challenging ‘brain training’—can enlarge hippocampal volume, improve objective cognition, and are linked to longer telomeres and longevity; VO2 max is a practical global fitness/brain‑health marker.

• Correctable medical issues commonly masquerade as cognitive disorders; vitamin B12 deficiency is frequent, often missed when levels are ‘low‑normal,’ and repletion toward an optimal range can reverse neuropsychiatric symptoms and brain fog.

• Social connection and intimacy support brain health, while loneliness and isolated lifestyles are associated with smaller hippocampi and higher Alzheimer’s risk; even pet ownership is linked with better cognitive outcomes.

• Genetic risk (e.g., APOE4) is not destiny: lifestyle interventions—especially regular physical activity and adequate sleep—can meaningfully reduce Alzheimer’s and stroke risk; up to 80% of strokes are preventable.

Clinical Insight

Treat the patient, not just the lab result: most cognitive complaints have multiple, modifiable drivers—systematically address whole‑body factors (sleep apnea, B12 status, vascular and metabolic health, stress, nutrition, physical fitness, and cognitive engagement) to improve objective cognition and reduce dementia risk, regardless of genetic predisposition.

Actionable Takeaway

In any patient with brain fog or cognitive complaints, check vitamin B12 with confirmatory markers (MMA and homocysteine when needed) and replete to an optimal level (often ≥500 pg/mL), then reassess cognition—this single, feasible step frequently yields rapid clinical improvement.

46. Health Longevity Secrets

EXPLAINER: Does Creatine Cause Cancer? What the Science Actually Says

Published: 2026-06-11

URL: Listen Here

Summary

This episode evaluates whether creatine increases cancer risk, contrasting a mouse study showing creatine-promoted metastasis with data indicating creatine supports antitumor immunity and human studies that do not show increased cancer risk. The nuanced conclusion is that risk is context-dependent: caution for patients with active/metastatic cancer, but no evidence to avoid creatine in generally healthy adults when using quality-controlled creatine monohydrate.

Key Takeaways

• Creatine has a context-dependent role in cancer biology: in mouse models with established tumors, supplemental creatine promoted metastasis via an MPS1→SMAD2/3 (TGF-β) signaling cascade that upregulated EMT genes (e.g., SNAI1/SNAI2).

• Tumor samples (e.g., liver metastases from colorectal and pancreatic cancers) show higher creatine kinase and SLC6A8 (creatine transporter) expression, suggesting tumors can hijack creatine metabolism.

• Conversely, creatine supports antitumor immunity by powering CD8+ T cells and dendritic cells; in mice it enhanced anti–PD-1 efficacy and slowed melanoma growth, while loss of the creatine transporter blunted immune responses.

• Human data do not show increased cancer risk from creatine: supplementation (2–20 g/day) did not raise urinary heterocyclic amines, higher dietary creatine intake in NHANES correlated with lower cancer risk, and a 2025 safety review found no substantiated human cancer risk.

• Practical framing: generally healthy adults likely do not face increased cancer risk from creatine; patients with active/metastatic cancer should discuss supplementation with their oncologist; use third‑party tested creatine monohydrate to minimize contaminant risk.

Clinical Insight

Creatine’s effects depend on disease context: while it can fuel metastasis in mouse models of established aggressive tumors, current human evidence does not support an increased cancer risk from creatine intake, and creatine may bolster antitumor immunity—so clinicians should individualize guidance, especially for patients with active or metastatic disease.

Actionable Takeaway

Screen oncology patients for creatine use; advise pausing supplementation and consult the treating oncologist if cancer is active/metastatic, while reassuring generally healthy adults that third‑party tested creatine monohydrate at standard doses appears safe based on current human data.

47. The Human Upgrade: Biohacking for Longevity & Performance

The Foods That Starve Cancer | William Li : 1481

Published: 2026-06-09

URL: Listen Here

Summary

Dr. William Li discusses how vascular health and angiogenesis balance underpin longevity, with evidence that dietary bioactives can influence cancer‑relevant pathways and that centenarian biology clusters around low inflammation, robust immunity, and healthier vasculature. He highlights practical measurement tools (FMD, PWV), the emerging cardiovascular risk signal from microplastics, and stress‑resilience strategies (vagal activation/HRV) as levers clinicians can apply now. Note: despite the episode title, specific food lists to ‘starve cancer’ were not detailed in this transcript segment.

Key Takeaways

• Food bioactives can modulate angiogenesis: in blinded in‑vitro testing, several food extracts matched or exceeded anti‑angiogenic cancer drugs in potency, supporting diet’s role in cancer defense and vascular health.

• Angiogenesis is a homeostatic system; endogenous growth factors and inhibitors dynamically balance vessel growth—clinical goals should emphasize vascular balance and resilience, not chronic inhibition.

• Centenarian research (including super‑agers) shows consistent signatures—stronger immunity, lower inflammation, healthier metabolism, gut, and vascular function—with longevity shaped by both genetics and lifestyle/exposures.

• Vascular resilience is measurable: flow‑mediated dilation (FMD) and pulse wave velocity (PWV) are practical markers that can be trended over time; better, accessible hardware paired with software is a key need.

• Microplastics are pervasive (notably from tire wear) and enter via gut, lungs, and olfactory pathways; their presence in carotid plaques correlates with higher inflammatory markers and ~4‑fold greater 3‑year risk of MI/stroke/death.

Clinical Insight

Microplastics embedded in carotid atheroma are associated with elevated inflammatory biomarkers and a markedly increased risk of major cardiovascular events, underscoring the importance of proactive vascular assessment and practical exposure‑reduction counseling in clinical practice.

Actionable Takeaway

Incorporate arterial stiffness/resilience tracking into midlife risk assessment—measure pulse wave velocity in clinic (or with a validated consumer device) annually and add flow‑mediated dilation where available; use trends to tailor interventions (exercise, diet quality, BP/lipid control) and recheck more frequently in high‑risk patients.

48. Lifespan with Dr. David Sinclair

The Longevity Revolution Is Here | Lifespan with Dr. David Sinclair - Season 2, Episode 1

Published: 2026-06-11

URL: Listen Here

Summary

Dr. Sinclair outlines the Information Theory of Aging and evidence that partial epigenetic reprogramming (OSK) can reverse age-associated decline—most notably restoring vision in animal models—now advancing to first-in-human trials (ER100) for glaucoma/NAION. He argues aging reflects degradable epigenetic instructions that can be reset without triggering oncogenesis, signaling a shift from disease management to functional rejuvenation. Clinicians should follow these developments closely while maintaining evidence-based care; note that some timelines (e.g., 2026 FDA clearance) reflect the host’s statements.

Key Takeaways

• The Information Theory of Aging posits that aging is driven primarily by loss of epigenetic information (cellular identity and gene-expression programs), not just accumulated molecular damage.

• Partial epigenetic reprogramming with OSK (Oct4, Sox2, Klf4; excluding Myc) reset DNA methylation clocks and restored visual function in aged and glaucoma-model mice, with supportive data in non-human primates.

• Life Biosciences’ ER100 (an OSK gene therapy) received FDA clearance to begin first-in-human trials for glaucoma and NAION, aiming to rejuvenate retinal ganglion cells and potentially restore vision.

• Experimental models (ICE mice) show that inducing repairable DNA breaks accelerates epigenetic aging, supporting causality between epigenetic information loss and aging phenotypes.

• Carefully controlled reprogramming separated rejuvenation from oncogenesis in animal studies, suggesting age reversal can be achieved without loss of cellular identity when precisely titrated.

Clinical Insight

Epigenetic information loss appears to be a causal and reversible driver of mammalian aging; tightly controlled, OSK-based partial reprogramming can restore function (including vision) without dedifferentiation, and is now being tested clinically in glaucoma/NAION.

Actionable Takeaway

Identify and counsel eligible patients with advanced glaucoma or NAION regarding potential enrollment in early-phase ER100 trials (monitor ClinicalTrials.gov for site openings) while continuing standard-of-care IOP reduction and vascular risk-factor management, emphasizing that vision-restoring reprogramming remains investigational.

49. The Human Upgrade: Biohacking for Longevity & Performance

World Cup, Sunscreen, Hair Regrowth, Caffeine Chewing Gum, and more... : 1483

Published: 2026-06-12

URL: Listen Here

Summary

This episode spotlights recent findings in longevity and performance to stress that delivery route and biological disposition largely drive outcomes. Highlights include GLP-1–linked shifts in epigenetic aging, cautious adoption of a newly approved UV filter, modest strength gains from buccal caffeine gum, vitamin A toxicity fueled by misinformation, and practical immune-preparedness steps for large events. The through-line helps clinicians translate emerging evidence into safer, mechanism-informed guidance.

Key Takeaways

• A Nature Communications randomized trial reported semaglutide slowed biological aging (~9% on DunedinPACE) and improved PC GrimAge in people with HIV-related metabolic disease, reinforcing the link between reduced metabolic inflammation and multi-organ aging markers.

• The FDA approved the broad-spectrum UV filter bemotrizinol (first new U.S. sunscreen active in ~20 years); despite favorable European experience and low-absorption claims, independent absorption data are still warranted—mineral blockers remain a conservative default.

• A systematic review of 21 studies found caffeinated chewing gum provides a small ergogenic boost for strength and countermovement jump (SMD ≈ 0.21) with no endurance benefit; buccal absorption speeds onset, making 5–25 minutes pre-training the key timing window.

• Vitamin A overdoses rose ~39% in Q1 2025 amid online claims it prevents/treats measles; high-dose preformed retinol can cause hepatotoxicity, intracranial hypertension, bone loss, and teratogenicity—its immune relevance does not justify megadosing.

• For mass-gathering exposures (e.g., the 2026 FIFA World Cup), pre-exposure ‘terrain’ readiness—eliminating sleep debt and alcohol, ensuring vitamin D and zinc are in range, and lowering inflammatory load 2–3 days prior—may improve immune resilience.

Clinical Insight

Pharmacokinetics and tissue fate (route of delivery, absorption, distribution, and accumulation) often determine both benefit and harm—clinicians should evaluate interventions through this lens, as illustrated by semaglutide’s systemic anti-inflammatory impact on epigenetic aging and the toxicity risk of fat-soluble vitamin A.

Actionable Takeaway

For patients without caffeine contraindications seeking a small strength/power edge, consider recommending caffeinated chewing gum 10–15 minutes before training or competition, noting the modest effect size and lack of endurance benefit.

50. This Week in Cardiology

Jun 12 2026 This Week in Cardiology

Published: 2026-06-12

URL: Listen Here

Summary

This episode critiques overreach in new syndromes and interventional adoption, emphasizing rigorous evidence appraisal. It highlights metabolic/lifestyle programs that improve outcomes around AF ablation, cautions against broad use of TTVR given null hard outcomes and substantial harms, reports neutral sepsis fluid strategy results with less pulmonary edema using restrictive approaches, shows no benefit of bicarbonate in in-hospital arrest, and documents a temporal decline in VT/ICD therapies that justifies re-evaluating primary-prevention ICDs in the modern GDMT era.

Key Takeaways

• Structured, lifestyle- and risk-factor–guided programs around atrial fibrillation (AF) ablation (ARREST-AF, POP-AF) produce meaningful weight loss, lower blood pressure, better symptoms, and fewer repeat interventions, while ablation remains superior to lifestyle plus antiarrhythmic drugs for rhythm control (PRAGUE-25).

• Transcatheter tricuspid valve replacement (TTVR) with the EVOQUE valve (TRISCEND II) improved subjective outcomes but did not reduce death, heart failure hospitalizations, or 6-minute walk distance, and was associated with high rates of severe bleeding (~15%) and new pacemaker implantation (~18%); a cost analysis underscores the burden of these complications.

• In early sepsis resuscitation (ARISE FLUIDS), restrictive fluids with earlier vasopressors versus liberal fluids yielded identical days alive and out of hospital at 90 days, with less pulmonary edema in the restrictive/vasopressor strategy—arguing against protocolized high-volume fluids as a blanket quality metric.

• For in-hospital cardiac arrest, the BIHCA randomized trial showed sodium bicarbonate does not improve return of spontaneous circulation or survival, providing strong evidence against its routine use.

• Appropriate ICD therapies—especially for ventricular tachycardia—have declined markedly over the last 15 years in European cohorts, likely reflecting improved GDMT, supporting equipoise to re-test primary-prevention ICD indications in modern care (e.g., PROFID).

Clinical Insight

Given the lack of hard-outcome benefit and the high complication burden in TRISCEND II, TTVR for secondary tricuspid regurgitation should be reserved for trials or highly selected patients after maximized medical therapy, with careful avoidance of indication creep.

Actionable Takeaway

Do not administer sodium bicarbonate routinely during in-hospital cardiac arrest; reserve it only for specific indications (e.g., severe hyperkalemia, tricyclic antidepressant overdose) and focus on guideline-directed ACLS (high-quality CPR, early defibrillation, timely epinephrine).

51. The Human Upgrade: Biohacking for Longevity & Performance

Just 1 Gram Activates Your Deep Focus Switch (Take THIS) : 1484

Published: 2026-06-14

URL: Listen Here

Summary

Dave Asprey argues that attention lapses stem from dips in key neurotransmitters and rising oxidative stress, positioning vitamin C as a core cofactor and antioxidant that can stabilize focus with a low-dose, pre-task protocol. He recommends 250 mg vitamin C (with optional NAC, CoQ10, PQQ, and L-theanine) and behavior/diet tweaks to improve transport and recycling, while cautioning against megadosing due to oxalate burden and kidney stone risk. The episode is largely promotional and does not cite primary studies; clinicians should apply judgment and evidence-based standards.

Key Takeaways

• The episode frames loss of focus as primarily a neurochemical and oxidative-stress problem in the prefrontal cortex (dopamine, norepinephrine, acetylcholine) rather than a willpower issue.

• Vitamin C is presented as central to maintaining steady neurotransmitter levels and providing antioxidant buffering in the brain; the host claims the brain stores high concentrations and that low levels can slow reaction time and increase mental fatigue.

• Suggested protocol: 250 mg vitamin C taken 30–60 minutes before deep work (option to split doses, use buffered forms with food if needed), while avoiding megadosing due to potential oxalate burden and kidney stone risk.

• Proposed factors that limit brain uptake include transporter function (vitamin C transporters, referred to as “SBCT2” in the episode), high blood sugar, chronic inflammation, suboptimal recycling; strategies include lower-glycemic intake around dosing, adequate sleep, hydration, magnesium, and omega-3 fats.

• Adjuncts suggested to reduce background oxidative stress and support energy: NAC (to raise glutathione and recycle vitamin C), CoQ10 and PQQ (mitochondrial support), and L-theanine (to temper glutamate-driven stress).

Clinical Insight

For clinicians, ensuring adequate—but not excessive—vitamin C intake may be a low-risk, potentially helpful strategy to support catecholamine synthesis and antioxidant defenses in patients reporting brain fog or attentional fatigue, while avoiding megadoses in those with kidney stone risk and acknowledging that evidence for acute cognitive enhancement with vitamin C is limited.

Actionable Takeaway

Consider a brief, monitored trial of low-dose vitamin C (250 mg orally, 30–60 minutes before cognitively demanding tasks, not exceeding 250 mg twice daily) in appropriate patients, coupled with counseling to avoid high-glycemic meals around dosing and to avoid megadosing, especially in those with a history of calcium oxalate nephrolithiasis.

52. The Peter Attia Drive

#396 ‒ Breast cancer screening: understanding risk, deciding when to start and how often to screen, and choosing the right imaging strategy

Published: 2026-06-15

URL: Listen Here

Summary

This episode presents a practical framework for individualized breast cancer screening: know your risk early, match modality and interval to that risk, and ensure consistent execution at high-quality centers. For most women, annual DBT starting at 40 is superior to biennial schedules; high-risk patients benefit from adding MRI (often abbreviated), with CEM as an alternative, while recognizing evidence gaps around scheduling and the need for prompt diagnostics for symptomatic disease.

Key Takeaways

• Personalize screening: complete a formal breast cancer risk assessment by about age 25 and incorporate breast density (BI-RADS C/D) because it both increases risk and reduces mammography sensitivity.

• For average-risk women, annual mammography—preferably with digital breast tomosynthesis (DBT)—from age 40 provides greater mortality reduction and earlier-stage detection than biennial schedules (CISNET modeling ~42% vs ~30% mortality reduction), with fewer false positives per exam due to better comparison images.

• High-risk women (e.g., lifetime risk ≥20%, pathogenic mutations, strong family history, prior chest radiation, or very dense breasts) should add breast MRI; abbreviated MRI preserves most sensitivity with lower burden. If MRI is not feasible, contrast-enhanced mammography (CEM) is a reasonable alternative; ultrasound adds variable, operator-dependent benefit.

• Start age should reflect risk: women in their late 30s with risk factors have detection rates several-fold higher than average-risk women in early 40s; consider a baseline mammogram in the 30s to establish density and initiate earlier, MRI-based protocols in clearly high-risk patients.

• Execution gaps are the main remediable problem: many eligible women are not up to date on mammography and MRI is vastly underused (~9% eligible vs ~0.4% utilization). Use high-quality, high-volume breast imaging centers and remember inflammatory breast cancer may evade routine screening—symptoms warrant prompt diagnostic workup regardless of a recent normal screen.

Clinical Insight

Early, formal risk stratification paired with annual DBT mammography for all and timely addition of MRI for women with ≥20% lifetime risk or dense breasts offers the highest-yield, evidence-aligned approach to reduce individual breast cancer mortality and interval cancers; underscreening and mismatched modality choice are the key remediable failures.

Actionable Takeaway

Implement a standardized clinic workflow: perform Tyrer–Cuzick (IBIS) risk assessment by age 25; order annual DBT mammography starting at 40 (earlier if above-average risk); add annual breast MRI (abbreviated acceptable) for patients with ≥20% lifetime risk, pathogenic mutations, prior chest radiation, or BI-RADS C/D density—use CEM if MRI is unavailable/contraindicated—and, when feasible, alternate MRI and mammography every 6 months at a high-volume breast imaging center.

53. Huberman Lab

The Mental Frame & Specific Daily Actions to Succeed | Andy Stumpf

Published: 2026-06-15

URL: Listen Here

Summary

This episode provides practical mental frameworks and daily behaviors—centered on the Influence vs Concern tool, micro-discipline, and strategic friction to curb social-media use—that enhance agency, focus, and resilience. Through Andy Stumpf’s experiences (special operations, wingsuit flight), it explores how calibrated challenges can improve attention and post-challenge clarity, and it candidly addresses suicide risk factors in veterans/high performers and the mixed but promising role of psychedelic-assisted care. Note: Summary based on an excerpted transcript; some topics from the full episode may not be captured.

Key Takeaways

• A simple weekly “Influence vs Concern” exercise (two-column list) powerfully redirects attention from uncontrollable worries to actionable behaviors, increasing agency and reducing rumination.

• Social media use behaves like a low-reward, high-stickiness addiction; even highly disciplined people revert without friction. Moving social apps to desktop-only and capping daily phone time improved mood and focus.

• Micro-discipline compounds: consistently choosing the slightly harder option (e.g., replace the toilet paper roll, make the bed, tidy up) builds perseverance circuitry and carries over to larger life goals.

• Deliberate exposure to challenge (e.g., cold, heat, strenuous training, demanding skill practice) can recalibrate time perception and attention, yielding post-challenge clarity and better decision-making; avoid cold immersion immediately after resistance training to prevent blunting hypertrophy.

• Suicide risk among veterans/high performers often includes isolation, alcohol misuse, identity loss after service, perfectionism/standards-gap, and pre-service trauma; psychedelic-assisted therapies can help some but not all, underscoring the need for honest dialogue, support networks, and targeted screening.

Clinical Insight

In high-functioning patients—especially veterans and elite performers—suicide risk often hides behind competence and stoicism; proactively screen for isolation, alcohol use, identity/purpose loss, perfectionistic self-standards, and pre-service trauma. Pair monitoring with concrete self-regulation tools (e.g., weekly Influence-vs-Concern worksheet, social-media friction) and timely referral to evidence-informed programs (e.g., vetted psychedelic-assisted therapy initiatives) when appropriate.

Actionable Takeaway

Prescribe a weekly “Influence vs Concern” worksheet: have patients list current worries (left column) and only direct-control actions (right), then schedule 1–3 right-column items for the week; augment with a 30-day phone-use cap (≤60 minutes/day) and move all social apps to desktop-only to reduce compulsive use.

Stay connected with Dr Onyx MD PhD for clinical insights and wellness tools that bridge science and everyday care:

Instagram ✦ X (Twitter) ✦ LinkedIn ✦ Website

From Insights to Action

Knowledge without execution changes nothing. The insights above only reach their full potential when integrated into a strategic, personalized plan. That’s where two offerings come in:

---

Personalized Medical AI Chatbot

Healthcare complexity is overwhelming. Clinical studies, conflicting guidelines, and fragmented records leave most patients paralyzed.

Deploy your Dr Onyx MD PhD Medical AI Chatbot—a personalized architecture that synthesizes your medical history, the latest research, and your unique condition into clear, actionable insights.

It’s not a replacement for your doctors—it’s your secret weapon for making better decisions and becoming the CEO of your own care.

👉 Deploy your Medical AI Chatbot today and take control of your health narrative

Premium Longevity Program

For people who know their most valuable asset is their health.

This year-long partnership delivers clarity, accountability, and physician-led execution. Stop collecting fragmented data and start acting on a ranked, strategic plan tailored to your biology and lifestyle.

👉 Discover the Premium Longevity Program and secure your health as your ultimate investment.